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Background: Paediatric broncho-alveolar lavage (BAL) is a minimally invasive procedure, 
performed during flexible bronchoscopy using isotonic saline to obtain a sample of bronchial 
and alveolar fluid from the distal lung. The BAL sample provides a determination of the 
different cell types that are present in the alveolar space as well as establishing the presence 
of lipid or haemosiderin in alveolar macrophages. In paediatric clinical practice, the patients 
that undergo BAL most frequently are children with chronic wheezing and recurrent chest 
infections as part of their workup to determine the possible cause. However, the interpretation 
of these results, in the clinical context is relatively uncertain. We therefore conducted this 
study in collaboration with the paediatric pulmonology unit at Tygerberg hospital in an 
attempt to determine if the BAL specimens can be used to categorize children with wheezing 
into either a gastro-eosophageal reflux or primary respiratory pathology group. We wanted to 
guage whether laboratory tests such as the differential cells counts; lipid-laden macrophage 
index, haemosiderin-laden macrophages index and number of  carbon-laden macrophages can 
be used as a marker for pulmonary pathology. To determine if BAL can assist with sub-
classification of the primary respiratory pathology group and determine if the amount of 
carbon-laden macrophages corresponds to the risk of increased lung disease 
Aim: Henceforth, we undertook this study to determine if the BAL specimens could be used 
to categorize these children as belonging to either the gastro-esophageal reflux or primary 
respiratory pathology group by grading the amounts of Oil red O lipid-laden macrophages 
(LLM) which is a marker for gastro-oesophageal reflux aspiration , Perl’s Prussian blue 
positive haemosiderin-laden macrophages(HLM) which serves to indicate the presence of 
pulmonary haemorrage and carbonladen macrophage (CLM) which may contribute to chronic 
lung disease, however has not yet been assessed in our setting. We also wanted to determine 
if the amount of phagocytosed carbon by alveolar macrophages had any correlation with 
chronic wheezing.   
Methods: Between march 2017 and march 2018, 68 paediatric patients presenting with a 
chronic wheeze underwent clinical investigations which included routine chemical pathology, 
microbiology and virology testing and the cytological evaluation of their BAL specimens. 
Once processed, the slides were stained with the Papanicolaou, Giemsa, Oil red O and Perl’s 
Prussian blue to quantitate the differential cell count as well as lipid-laden macrophage index, 




After a full clinical work-up, these patients were placed into a broad category of recurrent 
wheeze and recurrent infection, and sub-category groups of gastro-eosaphageal reflux disease 
(GORD), alveolar proteinosis, idiopathic pulmonary haemosiderosis (IPH), recurrent wheeze, 
infection/inflammation and structural abnormalities.    
Results: There was no statistical significance when comparing the cellular differential 
counts; carbon; lipid and haemosiderin-macrophages; tuberculosis investigations; cystic 
fibrosis investigations; virology investigations; microbiology investigations and c-reactive 
protein in the broad categories of recurrent wheezer vs. recurrent infection as well as 
subcategories of infection/inflammation, GORD, structural abnormality, idiopathic wheezer, 
IPF and alveolar proteinosis.  
Conclusion: The cytological investigation of paediatric BAL specimens continues to play a 
role in the clinical work up of children with chronic wheezing. This study did not manage to 
yield statistically significant data to identify a specific underlying cause and further research 







Agtergrond: Pediatriese brongo-alveolêre spoeling (BAS) is 'n minimaal indringende 
prosedure wat uitgevoer word tydens buigsame brongoskopie met behulp van isotoniese 
soutoplossings om 'n monster van brongiale en alveolêre vog te verkry. Die BASmonster help 
met die bepaling van die oorheersende seltipe en die bepaling van die teenwoordigheid van 
lipied of hemosiderien in alveolêre makrofage. In die kliniese praktyk is die pasiënte wat 
BAS gereeld ondergaan, kinders met chroniese fluit en herhalende borskasinfeksies as deel 
van hul kliniese ondersoek om die moontlike oorsaak te bepaal. Die interpretasie van hierdie 
resultate in die kliniese konteks is egter betreklik onseker.  Daarom het ons hierdie studie in 
saamwerking met die pediatriese pulmonologie-eenheid in die Tygerberg hopitaal uitgevoer 
in ‘n poging om vas te stel of die BAS monster kan gebruik word om kinders met ‘n 
chroniese fluit in ‘n gastro-oesofiese refluks of ‘n primêre repiratoriese patologiegroep te 
kategoriseer. Ons wou vasstel laboratoriumtoetse soos die differensiële seltelling olie-rooi O-
lipiedbelaaide makrofage, pruisiese blou positiewe hemosiderien belaaide makrofage en 
koolstof belaaide makrofage kan gebruik word as ‘n  merker vir pulmonale patologie. Om vas 
te stel of BAS kan help met die subklassifikasie van die primêre repiratoriese patologiegroep 
en bepal of die nommer van koolstof belaaide makrofage ooreenstem met die risko van 
verhoogtde longsiekte. 
Doelwitte:  Ons het hierdie studie onderneem om te bepaal of die BAS-monsters gebruik kan 
word om hierdie kinders te kategoriseer onder die gastro-esofageale refluks- of primêre 
respiratoriese patologiegroep. Daarvoor word die aantal olie-rooi O-lipiedbelaaide makrofage 
(LLM), Pruisiese blou positiewe hemosiderien belaaide makrofage (HLM) en koolstof 
belaaide makrofage (CLM) bepaal. Ons wou ook vasstel of die aantal gefagositeerde koolstof 
in alveolêre makrofage met chroniese fluit verband hou.  
Metodes: Tussen 13-Mar-2017 en-12-Mrt-2018, het 68 pediatriese pasiënte wat chroniese 
fluitbors gehad het, kliniese ondersoeke ondergaan wat roetine chemiese patologie, 
mikrobiologie en virologie-toetse en die sitologiese evaluering van hul BAS-monsters insluit. 
Nadat die skyfies gemaak is, is hulle met papanicolaou, giemsa, olie-rooi O en Pruisiese blou 
van Perl gekleur om die differensiële seltelling asook indekse van olie-rooi O-lipiedbelaaide 
makrofage, pruisiese blou positiewe hemosiderien belaaide makrofage ,en koolstof belaaide 
makrofage te kwantifiseer. Die beoordeling van die spesiale kleurmetodes is uitgevoer. Na 'n 




herhalende infeksie geplaas, en sub-kategorieë gastro-esofageale reflukssiekte alveolêre 
proteïnose,  idiopatiese pulmonale hemosiderose (IPH), herhalende fluit, infeksie / ontsteking 
en strukturele abnormaliteite.  
Resultate: Daar was geen statistiese beduidende resultate by die vergelyking van sellulêre 
differensiaalgetalle nie; koolstof; lipied- en hemosiderien-makrofage; tuberkulose 
ondersoeke; sistiese fibrose ondersoeke; virologiese ondersoeke; mikrobiologiese ondersoeke 
en c-reaktiewe proteïen in die breë kategorieë van herhalende fluitwaarde vs herhalende 
infeksie, sowel as subkategorieë van infeksie / inflammasie, gastro-esofageale reflukssiekte, 
strukturele abnormaliteite, idiopatiese fluit, IPF en alveolêre proteïnose.  
Gevolgtrekking: Die sitologiese ondersoek van pediatriese BAS-monsters speel steeds 'n rol 
in die kliniese opbou van kinders met chroniese fluit. Hierdie studie het nie statisties geslaag 
om ‘n spesifieke onderliggende oorsaak te identifiseer nie en verdere navorsing op hierdie 








I would like to thank my saviour, Jesus Christ, for granting me the wisdom to explore this 
topic; and the guidance, grace and strength to complete this degree.  
Philippians 4:13 “I can do all things through Christ who strengthens me.”  
  
I would like to express my unequivocal gratitude to my supervisor, Prof Pawel Schubert and 
collaborator, Prof Pierre Goussard for their guidance, insight, input and unsurpassed 
knowledge which they have shared with me.  
I would like thank my biostatistician Mr. Carl Lombard for performing statistical analysis.  
I would like to express my appreciation to the head of anatomical pathology Prof Johan 
Schneider and the NHLS for granting me this opportunity to execute this study.  
I would like to thank Mr. Dieter Geiger and Mr. Wayne Cole for their constant support and 
assistance.  
Finally, no dissertation can be claimed to be performed by one person. I would like to thank 
the staff working at TB culture, Microbiology, Chemistry, Histology and Virology for their 
assistance in helping me understand the clinical pathology and histological techniques 
employed.   
To my fellow colleagues who process and interpret bronchoalveolar lavage samples, the staff 
involved in retrieving slides, my manager as well as everyone else at Tygerberg cytology- 
Individual commitment to a group effort is what makes a team work, a company function 
efficiently and has the ability to impact society, no words can describe how thankful I am to 







I dedicate this dissertation to Jesus, the author, creator and one who directs my every step. I 
don’t want to do this life without your gentle guidance.  
In loving memory of my belated parents, Dawn and Anthony Marshall.  
Mom and dad, I know that you guys are smiling down from Heaven.  
To my loving family and friends, thank you for getting me through the tough times.  
To my dog Mikayla, thanks for being my study buddy. Finally, to Dr. Chase, thank you 
for imparting your wisdom and knowledge over tea. May the fruits of your labour 













Table of contents………………………………………………………………......…......ix-xiii  
List of Figures……………………………………………………………….……..……xiv-xv  
List of Tables………………………………………………………………..………….…....xvi  
List of Abbreviations………………………………………………….……………....xvii-xviii  
Glossary………………………………………………………………………..……....xix-xxiv  
Chapter 1: Literature Review……………………………………………………………….…1  
1.1. A brief history of the bronchoalveolar lavage, environmental air pollution  and the 
relation of ultrafine particles to lung disease development…………………………....1  
1.1.1. A brief history of the bronchoalveolar lavage technique……………………...1  
1.1.2. Structure of the lung and cellular constituents……………………………....1-2  
1.1.3. Environmental air pollution, ultrafine particles and the link to lung injury...2-3  
1.1.4. Impaired alveolar macrophage function in relation to clearance and retention of 
particulate matter and ultrafine particles………………………………….…...3-4  
1.2. Benign paediatric respiratory disease ……………………………………………….….4  
1.2.1. Chronic cough vs. chronic wheeze………………………………...…….…..4-5  
1.2.2. Serious underlying conditions associated with a typical or atypical chronic 




1.2.3. Underlying conditions in relation to particulate matter  and ultrafine particle 
exposure…………………………………………………………………………..………….7 
  
1.3 Clinical utility of BALF differential cell count, lipid-and haemosiderin laden 
macrophage index…………………………………………………………………………….8  
1.3.1 The diagnostic value of bronchoalveolar fluid cytology differential 
counts……………………………………………………………………………….8-9  
1.3.2 The role of the lipid-laden macrophage index in exogenous and endogenous  
lipid………………………………………………………………………………..9-10  
1.3.3 The haemosiderin-laden macrophage index in diffuse alveolar haemorrhage and  
haemosiderosis………………………………………………………………….......11  
1.3.4 The periodic acid-Schiff in alveolar proteinosis and interstitial lung 
disease………………………………………………………………………..…..11-12  
  
1.4. Cytological preparation, processing and interpretation of paediatric bronchoalveolar 
lavage fluid………………………………………………………………….…………12  
1.4.1 Bronchoalveolar lavage fluid transport and processing…………….….….12-13  
1.4.2 Manual cell counts vs. electronic cell counts…………………………..…13-14  
1.4.3 Quantitation of the lipid-laden macrophage index and the haemosiderin-laden  
macrophage index………………………………………………………………..14-15 
Chapter 2: Aim and study design…………………………………………………………….16  
2.1 Aim……………………………………………………………………………………….16  
2.2 Hypothesis……………………………………………………………………………..…16  
2.3 Study design and case selection…...……………………………………...………..…….16  
2.4Diagnostic categories………………………………………………………………….17-18  




2.6 Cytology differential count and special stain grading system.………………….........21-22  
2.7 Ethical approval…………………………………………………………………………..22 
Chapter 3: Materials and methods……………………………………………………………23  
3.1 Paediatric bronchoalveolar lavage fluid collection……………………………………..23  
3.2 Cytology processing of bronchoalveolar lavage fluid………………..……...……...23-24 
3.2.1 Specimen adequacy and haemocytometer manual cell counts ………......…..25-30 
3.2.2 Cytocentrifuge slide preparation……………………….........……………….30-31  
3.2.3 Papanicolaou staining technique.…………………………….........………....31-32  
3.2.4 Giemsa staining technique.……………………………………..........………....33  
3.2.5 Oil red O staining technique………………………………………...………..…33  
3.3 Histological staining techniques……………………………………………...…...…….33  
3.3.1 Perl’s Prussian blue staining technique…………………………..…………..31-34  
3.3.2 Periodic acid-Schiff staining technique………………………………..…..…....34  
3.4 Cytology differential counts and special stain quantitation ……………..……….….....34  
3.4.1 Differential cell counts………………………………………………..….…34-35  
3.4.2 Alveolar  macrophage  quantitation  for  lipid,  haemosiderin  and 
carbon……………………………………………………………..….…….35-37 
3.4.3 Periodic acid-Schiff……………………………………………….……..…..…37  
3.5 Pulmonary tuberculosis investigations………………………………...………………37  
3.5.1 Gene Xpert Ultra………………………………………………………………..37  
3.5.2 TB culture………………………………………………………..……..….…....38  
3.5.3 Auramine O staining procedure and reporting……………………….…….….....38  




3.6.1 Bronchoalveolar lavage fluid gram stain……………………………..………38-39  
3.6.2 Bronchoalveolar lavage fluid culture…………………………………………..39  
3.7 Chemical pathology investigations………………………..…………………..…….….39  
3.7.1 Sweat test………………………………………………………….……....….…39  
3.7.2 Serum IgA……………………………………………………..…….…………..40  
3.7.3 Serum IgG…………………………………………………………...……..…...40  
3.7.4 Serum IgM………………………………………………………..…....…….40 -41 
3.7.5 C-reactive protein……………………………………...……..…………..……..41  
3.8 Virology investigations…………………………………………………………….…...41  
3.8.1 Respiratory virus multiplex polymerase chain reaction…....……….…………...….41-42  
3.8.2 Cytomegalovirus polymerase chain reaction…………………………………….……42  
  
Chapter 4: Results………………………………………………………………………....…43  
4.1 Mean age in months……………………………………………….……........….……43-44  
4.2  Cytology count results………………………………………………..……………….…44 
4.2.1  Differential count results……………………………………………………..….…44-46  
4.2.2  Carbon, lipid and haemosiderin-laden macrophage results……………….....….…46-49  
4.2.3   Periodic acid-Schiff results………………………………………………….………...50  
43 Pulmonary tuberculosis investigations results………….………………………...............50 
4.4 Microbiology investigation results………………………………………….……………50  
4.4.1 Gram stain results………………………………………………………..……….…50-51  
4.4.2 Culture results………………………………………………………………...….…51-52  




4.5.1 Sweat test results………………………………………………………………..……..52  
4.5.2 IgM results…………………………………………………………………......52-53  
4.5.3 IgG results…………………………………..………………………….….……….54  
4.5.4 IgA results…………………………………………………………..….…….….…55  
4.5.5 C-reactive protein results……………………………………………….………….56  
4.6 Virology investigation results……………………………………………………..…..…56  
4.6.1 Respiratory virus multiplex comparison between recurrent wheezer vs.  
infection……………………………………………………………...………………56-57 
 4.6.2  CMV  results…  comparison  between  recurrent  wheezer  vs.  
infection………………………………………………………..………….…………….57  
Chapter 5: Discussion ………………………………………………………………………..58  
5.1 Discussion……………………………………………………………………..…58-60  








List of Figures  
    
Figure 1.1:    Colombo and Hall score for lipid-laden macrophage…………..….…...…15  
Figure 1.2:  
 
Golde score for haemosiderin-laden macrophages…………….….……...15  
Figure 2.1:    
Final diagnostic outcomes, diagnostic main categories and 
subcategories……………………………………………………………....18  
Figure 2.2:   
Final diagnostic main category and sub-category comparisons of laboratory  
findings…………………………………………………………...……....21  
Figure 3.1:    Illustration of paediatric BALF specimen cytology processing….…….....23  
Figure 3.2:  
 
Haemocytometer counting chambers……………………………...……...26  
Figure 3.3:   Loading  of  specimen  and  quantitation  of  cells 
 using  a 
haemocytometer……………………………………………………….......27  
Figure 3.4:    
(a) Cytospin apparatus unassembled…………………………………......31  
(b) Cytospin apparatus assembled with coinciding filter and funnel  
holes…………………………………………………………….…….……31  
Figure 3.5:    
(a) Papanicolaou stained slide for differential cell counts……..………....35 
(b) Giemsa stained slide for differential cell counts………….….………..35  
Figure 3.6:  
 
 (a) Class I lipid-laden alveolar macrophage………………….…………...36  
  
 
(b) Class II lipid-laden alveolar macrophage………………….…………..36  
  
 
(c)Class III lipid-lade alveolar macrophage………………………….…..36  
  
 
(d) Class IV lipid-laden alveolar macrophage…………….……………….36  
Figure 3.7:   
 
 (a) Class I haemosiderin-laden alveolar macrophage…….….……………36  
  
 
(b) Class II haemosiderin-laden macrophage………………….………..…36  
  
 
(c) Class III haemosiderin-laden alveolar macrophage……………………36  




Figure 3.8:  
 
 (a) Class I carbon-laden alveolar macrophage………………………37  
  
 
(b) Class II carbon-laden alveolar macrophage……………..……….37  
 Figure 3.9:     (a) PAS negative alveolar macrophage……………………...…...…37  
  
 
(b) PAS positive alveolar macrophages…………………….......……37 
Figure 4.1:   
 
Main category age in month’s comparison……………………….….43 
Figure 4.2:  
 
Sub-category age in months comparison………………………….….44  
Figure 4.3:   
 
Main category differential cell count comparison……………….…...45 
Figure 4.4:   
 
Sub-category differential cell counts comparisons……………….….45 
Figure 4.5:    
(a) Main category comparison of ORO variable. ………………..….47  
(b) Main category comparison of Perl’s variable…………………….47  
(c) Main category comparison of carbon variable………………...….47  
Figure 4.6:    
(a) Sub-category comparison of ORO variable………………………48 
(b) Sub-category comparison of Perl’s variable………………..…….48  
(c) Sub-category comparison of carbon variable…………………….48  
Figure 4.7:  
 
 Age adjustment comparison of sub-groups to Perl’s variable.………49  
Figure 4.8:   
 Microbiology gram stain results comparison between recurrent wheezer 
and recurrent infection………………………………..…………………51  
Figure 4.9:   
 
CMV virology results comparison between recurrent wheezer and  






List of Tables  
    
Table 3.1:     Manual haemocytometer count requiring no dilution…………..……28  
Table 3.2:    Manual haemocytometer count requiring a 4x dilution………..….…28  
Table 3.3:    Manual haemocytometer count requiring a 8x dilution…………..….29  
Table 4.1    Main category comparison of differential cell counts………….…….44  
Table 4.2:    
Main category comparison of ORO; haemosiderin and carbon  
variable…………………………………………………...………….…46  
Table 4.3:   
Sub-category  comparison  of  carbon  ORO  and  haemosiderin  
variables……………………………………………………..….……47  
Table 4.4:   
Sub-category comparison of carbon, lipid and haemosiderin against a 
constant (GORD)………………………………………………….48-49 
Table 4.5:   
 Main  category recurrent wheezer and recurrent infection gram stain  
comparison……………………………………………………………50 
Table 4.6:    
Main category recurrent wheezer and recurrent infection BALF 
microbiology culture sample outcome comparison………………........51  
Table 4.7:    
 Main category recurrent wheezer and recurrent infection BALF 
microbiology cultured species comparison……………………….....…52 
Table 4.8:      Main category  IgM comparison……………………………………….53  
Table 4.9:      Sub-category IgM comparison………………………………….……...53  
Table 4.10:    Main category IgG comparison……………..……………………...….54  
Table 4.11:     Sub-category IgG comparison…………………………………..…..…54  
Table 4.12:     Main category IgA comparison………………………………......……55  
Table 4.13:     Sub-category IgA comparison…………………………………………55  
Table 4.14:     Sub-category C-reactive protein comparison………………………….56  





List of Abbreviations  
 
1. AM     Alveolar Macrophage  
2. AO    Auramine O  
3. BAL    Bronchoalveolar lavage  
4. BALF Bronchoalveolar lavage fluid  
5. CB    Carbon black  
6. CF    Cystic fibrosis  
7. CLM   Carbon-laden macrophage  
8. GORD  Gastro-oesophageal reflux disease  
9. HLM   Haemosiderin-laden macrophage  
10. HLMI Haemosiderin-laden macrophage index  
11. GXP    GeneXpert  
12. ICC    Immunocytochemical stain(s)  
13. IgA    Immunoglobulin A  
14. IgG    Immunoglobulin G  
15. IgM    Immunoglobulin M  
16. IHC    Immunohistochemical stain(s)  
17. LLM   Lipid-laden macrophage  
18. LLMI   Lipid-laden macrophage index  




20. NHLS  National Health Laboratory Services   
21. ORO    Oil Red O stain  
22. PAP    Papanicolaou stain  
23. PBB    Perl’s Prussian blue stain  
24. PCD    Primary ciliary dyskinesia  
25. PCR    Polymerase chain reaction  
26. PCT    Procalcitonin  
27. PTB    Pulmonary tuberculosis  
28. PM    Particulate matter  
29. RT-PCR  Reverse transcriptase polymerase chain reaction  
30. SOP    Standard operating procedure  















    
Allergy    An excessive or inapt immune reaction to an 
environmental agent (antigen).  
Amyloid    An insoluble extracellular material that when deposited, 
causes hardening, enlargement and malfunction of 
organs.  
Antibody     An immunoglobulin specific for a certain antigen.  
Antigen     A substance binding to a particular antibody or antigen 
receptor.  
Atopy    The genetic predisposition to develop allergic 
conditions and hypersensitivity conditions especially to 
inhaled and food allergens.  
Autosomal (gene)    A gene residing on one of the 22 chromosomes other 
than a sex (X or Y) chromosome.  
Axoneme     A fibrillary bunch whip-like appendages or cilia that 
usually consist of 9 microtubule pairs arranged around 
one single central pair.  
Basophil     A bone marrow derived white blood cell with uniform 
blue-black granules involved in the immune response.  
Basophilic     A cell or its components which has an affinity for a 
basic dye such as haematoxylin. Often staining dark 
blue in colour.  
Biomass fuel    Plant or animal derived matter used for energy 
production such as heat or electricity.  
Bronchiectasis      Irreversible dilation of the bronchi.  




Cilia   Fine hair-like structures projecting from certain cells 
such as those seen in the respiratory tract which assist in 
sweeping particulate matter along the mucociliary 
escalator.  
Cytocentrifuge                                   A low-speed, low-acceleration centrifuge used to  
separate and deposit cells suspended in a liquid without 
damaging them on a slide for microscopic examination.  
Cyanophilic  A cell or its components which have an affinity for blue 
and green dyes such as polychromatic EA-50.  
Dendritic cell  An antigen presenting cell acting as a messenger     
between the innate and adaptive immune system. Its 
primary role is to process antigens and present them to 
the cell surface receptors of T-lymphocytes.  
Eosinophil  A bone marrow derived white blood cell involved in the  
immune response launched against foreign substances 
and parasites.  
Eosinophilic  cytoplasmic components which take up eosin dye and as 
a result stain bright pink.  
Extrinsic                                           Pertaining to a cause outside a structure in the body  
causing compression and/or obstruction, or a cause 
external to the body.  
Ferritin        A protein on erythrocytes responsible for storing iron.  
Ferrocyanide  A salt containing the anion Fe(CN)6
4−
 2 used to produce a 
blue pigment.   
Fixation:                                            Immobilizing preserving, visualizing and hardening  





Free radicals  Chemical  radicals  with  highly  reactive  
 unpaired electrons in their outer shell composition.  
Glycogen   A carbohydrate polysaccharide substance deposited in 
tissues which forms glucose on hydrolysis.  
Glycoprotein    A type of protein molecule that has a carbohydrate 
attached to it.  
Good-pasture’s syndrome   An autoimmune disease that attacks the lungs and 
kidneys.  
Granulocyte    A category of white blood cells characterized by 
cytoplasmic granules which are released during 
infections, allergic reactions and asthma. They are also 
known as polymorphonuclear cells. These include 
neutrophils, eosinophils and basophils.  
Granuloma    A structure formed during inflammation found in 
numerous diseases. Aggregates of epithelioid 
macrophages form, often including multinucleated giant 
cells which are also derived from macrophages 
(histiocytes) when the immune system attempts to wall 
off substances which it perceives as foreign but is 
unable to eliminate it.  
Haematamesis      The vomiting up of blood.  
Haemoglobin    A red iron containing protein in erythrocytes 
responsible for transporting oxygen via the blood to 
tissue.  
Haemosiderin     A yellowish-brown granular pigment formed by the 




Hilum     A wedge shaped section on the central middle aspect of 
each lung where bronchi, arteries, veins and nerves 
enter and exit the lung.  
Hypersensitivity pneumonitis  Also known as extrinsic allergic alveolitis is a type of  
interstitial lung disease characterized by a immune  
mediated hypersensitivity inflammatory reaction to 
inhaled organic substances.  
Hypochromasia       Pale staining nuclear chromatin.  
Idiopathic pulmonary fibrosis  A category of chronic lung disease characterized by 
scarring/fibrosis of the lung for an unknown reason.  
Immunocytochemistry   A laboratory staining technique used to demonstrate 
proteins and peptides on cytology specimens.  
Immunohistochemistry   A laboratory staining technique used to demonstrate 
antigens using various antibodies on histology 
specimens.  
Lamellar body   Secretory organelles found in type II pneumocytes of the 
lung and keratinocytes in the skin.  
Lipoprotein    A substance containing both protein and lipid that 
transports lipid in the blood.  
Mucociliary escalator   The self-clearing mechanism of the respiratory system 
to remove inhaled particulate and trapped substances 
from the airways.  
Mucostasis         Stopping the secretion of mucus.  
Monoclonal antibody   An artificially produced antibody produced by a single 
clone of cells or cell line.  
Opsonisation    A process whereby opsonins such as antibodies coat 
foreign material and micro-organisms rendering them 




Organizing pneumonia  
 
Buds of granulation within the alveolar spaces which  
progress from fibrin exudate to loose collagen 
containing  fibroblasts subsequently forming collagen 
plugs within the alveoli.  
 
Pathogenicity   The ability of a micro-organism to cause disease  based 
on its virulence (high/low).  
Phagocytosis        Ingestion of a particle or micro-organism by a cell  
Pneumonia   Inflammation of either one or both lungs as a result of a 
bacterial or viral infection in which the alveoli become 
filled with an inflammatory exudate.  
Polyclonal antibody  A collection of immunoglobulins made up by antibodies 
secreted by various B cell lines within the body to react 
against a specific antigen.  
Polycyclic hydrocarbon  Organic compounds consisting of only carbon and 
hydrogen.  
Polymerase chain reaction  A laboratory technique used to make multiple copies of 
a strand of a specific DNA or RNA segment.  
Primer (molecular biology)  The strands of DNA or RNA serving as the initial 
foundation in the replication process and is used in the 
demarcation of the template strand to be amplified. 2 
primers are therefore “matched” to the segment strand 
of DNA/RNA.  
Probe   A blunt ended surgical instrument used to examine a 
wound or section of the body.  
Psychogenic  A condition manifesting from a psychological origin as 
opposed to a physical one.  
Real time PCR  Also amplification is detected in “real time” by using a 
fluorescent reporter. The signal strength of the 
fluorescent reporter is directly proportional to the 




Reverse-transcriptase PCR  A variation of the PCR method whereby the presence 
and amount of RNA is detected.   
Recessive (genetics)  A heritable characteristic expressed in offspring when 
inherited by both parents. Such as the gene for blue 
eyes. A recessive gene can be masked by a dominant 
gene as is seen in the dominant gene for brown eyes.  
Reticuloendothelial system   The mononuclear phagocytic system in the body 
consisting of various cells with the primary function to 
remove foreign substances, dead and abnormal cells.  
Sputolysin         A mucolytic agent capable of thick mucus.  
Trypan blue  An azo dye used as a biological stain to colour live cells 
of the reticuloendothelial system such as macrophages 
with intact membranes due to its absorption.  
Virulence  
  




The ability of a micro-organism to cause disease. 
Pathogenicity is based on a micro-organism’s virulence 
factors such as adhesins, anti-phagocytic factors and 






Chapter 1: Literature review  
  
1.1 A brief history of the bronchoalveolar lavage,
 environmental air pollution and the relation of
 ultrafine particles to lung disease development.  
  
1.1.1 A brief history of the bronchoalveolar lavage technique.  
Bronchoalveolar lavage (BAL) allows for the sampling of the peripheral lung. This is a 
minimally invasive procedure with a low morbidity and is performed under local anaesthesia 
in adults and general anesthesia in children. Specimens are obtained by wedging a sub-
segmental bronchus with the bronchoscope and lavaging the area with warm isotonic saline. 
Numerous consecutive fluid instillations of 20-100ml aliquots are performed, flooding the 
distal airspace before re-aspiration. The aspirated fluid should contain very few bronchial 
cells. BAL fluid can assist in differentiating between inflammatory processes which are 
lymphocyte predominant from those which are macrophage or neutrophil predominant.  In 
addition, the presence of haemosiderin-laden macrophages and lipid-laden macrophages may 
aid in the diagnosis of pulmonary haemosiderosis and lipid pneumonia respectively. 
1,2
  
                                               
1 .1.2 Structure of the lung and cellular constituents.  
The respiratory tract is divided into the upper and lower respiratory tract respectively. The 
upper respiratory tract consists of the nasal cavity, paranasal sinuses as well as the pharynx. 
The lower respiratory tract comprises of the larynx, trachea, bronchi, bronchioles and alveolar 
ducts and sacs.   
The trachea bifurcates into the left and right main bronchi at the carina. These bronchi 
undergo further branching until they form bronchioles. The bronchial tree is lined by 
pseudostratified glandular epithelium consisting predominantly of ciliated columnar and 
mucin-producing goblet cells. Cilia play a pivotal role in ensuring that mucus-trapped inhaled 
particulate matter swept upwards via the mucociliary escalator.  Terminal bronchioles further 




pneumocytes, the latter are surfactant secreting cells with the former being modified 




1.1.3 Environmental air pollution, ultrafine particles and the link to lung injury.  
The lung is well evolved to handle airborne dust particles that are inhaled and deposited. 
Inhaled particulate matter may be divided into fibronic or non-fibronic. Fibronic particles 
such as asbestos and quartz are evidently pathogenic to the lung; however, non-fibronic 




There are 4 types of macrophages found in the lung. These are the alveolar; interstitial; 
intravascular macrophage and the dendritic cell, with the alveolar macrophage being the only 
macrophage that is exposed to air. It has been observed that carbon pigment, which is black in 
colour, is not formed in vivo, but inhaled and ingested by alveolar macrophages. These 




The worldwide urban population is projected to rise to 6.5 billion by the year 2050.
6
  
Particulate matter (PM) in air pollution is a mixture of solid and liquid particles varying in 
number, size, surface area, chemical composition and origin. 
7
PM is broadly classified 
according to aerodynamic diameters:  
• PM10: Coarse particles with a median aerodynamic diameter of 10µm or less.  
• PM2.5: Coarse particles with a median aerodynamic diameter of 2.5µm or less.  
• UFP<0.1: Ultrafine particles with a median aerodynamic diameter of  0.2µm or less.7  
Most particles acquired from the ambient atmosphere of urban settings range in size from 
0.05-0.2µm, with a chemical composition consisting half of carbon and half of salts such as 
ammonium sulphate or ammonium nitrate. Polycyclic aromatic hydrocarbons bind with diesel 
engine exhaust emissions and accounts for approximately 90% of the total particle mass in 
urban areas and major cities such as London.
8
 Inhaled ambient PM10 is more likely to be 
removed by mucociliary clearance. Previous studies utilizing radioactive particles have 
demonstrated that particles with a median diameter of 2.5µm undergo a total lung deposition 




retention time when compared with PM10.
8
  This appears to be as a result of mass vs surface 
area of a particle. Albeit that the mass of a 0.1µm particle is smaller than that of a 1µm 
particle, the surface area of the 0. 1µm particle is tenfold greater than that of the 1µm particle. 
As the particle decreases in size, its surface area and capacity to carry toxic substances and 
free radicals increases. More free radicals have been found in UFP samples in comparison to 
coarser particles of the same substance. The consequences of PM and UFP exposure and their 
ability to carry toxic substances and free radicals, and the associated inflammatory response 
manifests as cardiorespiratory diseases and respiratory morbidity in children, especially in 
poor socioeconomic areas where the population is dependent on burning of biomass and solid 
fuels for heating and cooking, overcrowding and exposure to second hand tobacco smoke. 
Individuals who are more prone to developing the PM associated manifestation are those who 
spend lengthy periods of time near the source of  solid fuel combustion, such as women and 
children.
6,8,9
   
The human respiratory system has 5 stages of development, with the last stage ranging from 
37 weeks of gestation to approximately 20 years of age. Children exposed to air pollution and 
second hand tobacco smoke are more susceptible to the effects due to behavioral and 
physiological factors. For example, higher rates of mouth breathing have been observed in 
children, which is increased by 20% during increased physical activity. Minute ventilation 
rate in relation to body size coupled with ineffective PM removal by the upper respiratory 
tract due to increased mouth breathing leads to an increased amount of PM deposition in the 
lungs. In addition, exposure to environmental tobacco smoke has been linked with an 
increased prevalence of lower respiratory tract infections such as asthma, bronchitis, 
bronchiolitis and pneumonia. Adverse changes in lung function related to PM2.5 and UFP 
therefore present at an earlier stage in children. 
10–12
  Interestingly, it has also been described 
that the overall lung health of children improved in California when the federal state emission 





1.1.4 Impaired alveolar macrophage function in relation to clearance and retention of 
particulate matter and ultrafine particles.  
The alveolar macrophage is derived from bone marrow monocytes and is a component of the 




macrophages are primarily involved in the processing and transfer of antigens to lymphoid 
receptors compared to alveolar macrophages. Its principal role is to ensure that alveolar 
surfaces are void of exogenous agents by phagocytosing foreign material, thus protecting the 
lung from inhaled substances (including bacteria) which evade mucociliary clearance and 
potentially cross the epithelial barrier to the pulmonary interstitium.
7,14
 Alveolar macrophages 
phagocytose particles in an opsonin-dependent manner using scavenger type receptors before 
migrating to the bronchoalveolar junction where accumulation and aggregation occur.  High 




Numerous animal models have been used to demonstrate the relationship between the 
toxicology of PM and the clearance and retention thereof in the lung. It was proposed by 
Morrow et al
15 
that the impairment of particle clearance is attributed to the volumetric loading 
of alveolar macrophage. He suggested that impaired phagocytosis occurs when the composite 
phagocytosed volume exceeds 6% and that complete cessation of clearance happens at 60%.  
Both clearance mechanisms and migration of alveolar macrophages have been shown to be 
impaired as a result of PM exposure.
8,15,16
 An impairment of clearance was demonstrated at 
2.6% of phagocytosed volume with emphasis placed on UFP.
10,17
 Under increased and 
continued PM and UFP loading, clearance thereof is slowed, this is observed in sputum 
samples of ex-mine workers with a halftime of approximately 5 years, and the chronic build 
up may lead to inhibition of the phagocytic function of the macrophage.
14,18–20
   
  
1.2 Benign paediatric   pulmonary disease.  
  
1.2.1 Chronic cough vs. chronic wheeze.  
A cough is a normal protective physiologic reflex aiding in the clearance of both airway 
secretions and aspirated material. A cough may be the only presenting symptom of a more 
serious underlying condition and becomes abnormal when the frequency and severity affects 
the child’s ability to eat, sleep, play or learn.  
Most coughing episodes in children are acute, lasting approximately <3 weeks, and are 
secondary to a lower respiratory tract infection. A cough with a duration of 3-8 weeks is 




classified as chronic cough. In addition to duration and the likeliness of an underlying 
condition, the quality and pattern may also be assessed with regards to wet; moist; productive 
and dry.21,22  
A physician faced with a child who has a non-specific symptom, such as a chronic cough is 
faced with placing the child into one of the following categories:  
• Normal child.  
• Overestimation of symptoms including psychogenic.  
• A child with asthma syndrome.  
• A child with a serious illness (Tuberculosis or cystic fibrosis).  
• A child with a non-serious treatable cause of cough with our without a wheeze (postnasal 
drip or gastro-oesophageal reflux disease).
23
  
A wheeze is defined as continuous high-pitched sounds possessing a musical quality from the 
chest on expiration. A wheeze should be confirmed by a physician as they can also determine 
the severity of the wheeze.
24
 Fifty percent of wheezing is observed in children of preschool 
age, <6 years of age. If a wheeze is recurrent, it and may be classified as typical or atypical. 
Conditions such as asthma; bronchitis and bronchiolitis are associated with typical wheeze. 




1.2.2 Serious underlying conditions associated with a typical or atypical chronic cough 
and wheeze.  
Neonatal onset of cough may be suggestive of primary cilia abnormality; lesions compressing 
the airways; bronchiolitis or chronic viral pneumonia.  
  
1.2.2.1 Asthma: Associated with exposure or situation and may be categorized as acute or 
chronic. Triggers which cause a hypersensitivity reaction and airway obstruction 
include exercise; bacterial or viral infection; stress; medications and inhaled allergens 




1.2.2.2 Chronic bronchitis: Associated with a chronic cough and sputum production for 
more than 6 months.
26
  
1.2.2.3  Gastro-oesophageal reflux disease: Associated with organizing pneumonia and  
Reflux aspiration may be associated with or without gastric content.
27
  
1.2.2.4  Bronchiectasis: Defined morphologically as the irreversible, abnormal dilation of 
bronchi and bronchioles. Mainly related to an underlying condition of mucostasis and 
chronic infection (particularly Tuberculosis in the South African context).
28
  
1.2.2.5 Pulmonary tuberculosis: Caused by the acid-fast lipid rich Mycobacterium 
tuberculosis and is spread via airborne droplet nuclei 1-10µm in size. Once 
phagocytosed, tubercle bacilli replicate within the cytoplasm of alveolar macrophages 
and spread to the lymphatics and bloodstream and spread to distant organs. When the 




1.2.2.6  Bronchogenic cysts: Congenital cysts found predominantly in the anterior hilum or 
mediastinum. Cyst fluid is found within a thickened fibrous wall and may be clear or 
infected, containing pus and haemorrhage.
30
  
1.2.2.7  Primary ciliary dyskinesia: An autosomal-recessive condition causing the primary 
abnormality of the axoneme dynein arms which drive the beating of cilia. Sixty five 
percent of patients have a shortening or absence of the outer dynein arm resulting in 
an ineffective mucociliary escalator thus increased infection and bronchiectasis.
30
  
1.2.2.8 Cystic fibrosis: An autosomal-dominant condition resulting in an amino acid deletion 
of phenylalanine of the cystic fibrosis transmembrane conducting regulator gene on 
chromosome 7. The protein encoded by the mutant gene resides on the apical 
membrane of epithelial cells causing decreased permeability of chloride transport 
across epithelial membranes. The correct composition of water and electrolytes in 
epithelial secretions is altered resulting in thick mucus accumulation. This is 
accompanied by repeated infections with acute inflammation in the lungs. Patients 
with cystic fibrosis are prone to recurrent chest infections and bronchiolitis due to 
distended mucus glands with inspissated mucus in the airways. A relatively simple 






1.2.2.9  Pneumonia: Presents as an acute illness. May be acquired through inhalation or 
aspiration. It may be either infective (bacterial, viral, fungal or parasitic) or non-




1.2.3 Underlying conditions in relation to particulate matter and ultrafine particle 
exposure.  
Asthma is characterized by airway obstruction with an increase in alveolar volume resulting 
from air trapping. It would be expected that there would be enhanced PM diffusional 
deposition associated with increased alveolar volume. Those therefore suffering with asthma 
appear to have exacerbations when exposed to air pollution. Increased levels of air pollution 
are not only associated with asthma exacerbations, but also increased hospital admissions.
7,32
  
One such study estimated the risks of various types of PM2.5 on hospital admissions for 
respiratory diseases among children.
33
 Elemental and organic carbon, various metals and 
silicone were measured as components are found in biomass burning; diesel and motor 
vehicle emissions and other fuel combustion processes. Their study revealed that hospital 
admissions for childhood respiratory diseases, especially pneumonia, were associated with 
PM2.5 exposure. Another study explored the association between environmental carbon and 
lower lung function in schoolchildren.
12
 Fifty five asthmatic and forty non-asthmatic children 
were included in this study. Their findings revealed that the association between 
environmental carbon and decreased lung function was seen in both asthmatic and non-
asthmatic children.   
The effect of environmental tobacco smoke has also been described to be associated with 
increased incidences of wheeze up to the age of 6 years of age with an odds ratio of 1:31. 
Children in smoking households have an increased incidence of cough, phlegm production, 








 1.3 Clinical utility of BALF differential cell counts,
 lipid-laden  and haemosiderin-laden macrophage
 index.  
  
1.3.1 The diagnostic value of bronchoalveolar lavage fluid cytology differential counts.  
In normal individuals 80-90% of cells recovered from BALF are macrophages, followed by 
5-15% lymphocytes, less than 3% neutrophils and less than 1% eosinophils.
34
 Limited data 
exists about the cellular components found in bronchoalveolar lavage fluid of normal children 
due to ethical reasons as this procedure is not normally performed on normal children, only 
on children who have pulmonary pathology warranting further bronchoscopic investigation. 
One study using 50 children aged 3-16 years, undergoing elective surgery for non-pulmonary 
illnesses found that macrophages were the predominant cell type followed by lymphocytes. 
Thisstudy also revealed that there was a higher granulocyte count in younger children with 
the neutrophil count being higher than that of eosinophils and basophils.
35
 In conditions such 
as idiopathic pulmonary fibrosis, there is no specific diagnostic feature; however the 
differential count may provide useful information. In this case, neutrophils are the main 




Below are the various differential cell count patterns and associated percentages which are 
indicative of various lung diseases.
34,37,38
  
• Lymphocytic patterns with a lymphocyte count greater than 15% are seen in 
conditions such as non-specific interstitial pneumonia, hypersensitivity 
pneumonitis and drug-induced pneumonitis. A lymphocytic percentage greater 
than 50% is highly suggestive of non-specific interstitial pneumonia or 
hypersensitivity pneumonitis.  
• Neutrophilic cell patterns with a neutrophils count of more than 5% are seen in 
idiopathic pulmonary fibrosis, aspiration pneumonia, bacterial and fungal 
infection, diffuse alveolar damage and bronchitis. A neutrophil percentage 
greater than 50% strongly suggests pneumonia, lipid pneumonia, lung abscess 




• Eosinophilic patterns yielding an eosinophilic count greater than 3% are seen 
in eosinophilic pneumonia, drug induced pneumonitis, asthma, bronchitis, 
bacterial infections, parasitic infections and fungal infections. An eosinophilic 




1.3.2 The role of the lipid-laden macrophage index in exogenous and endogenous lipid.  
The accumulation of lipid within alveolar macrophages occurs as a result of phagocytosis of 
external lipid and lipoproteins. This may also be secondary to endogenous sources as is seen 
in lipid pneumonia as a result of a chronic lung infection or bronchial obstruction.   
Exogenous sources however are as a result of either aspiration or inhalation of lipid.
39
 The 
laryngeal reflex protects the airways from coming into contact with gastric and oral content. 
Chronic respiratory disease in children may arise as a result of recurrent pulmonary 
aspiration. Forty to fifty percent of infants with gastro-oesophageal reflux disease (GORD) 
present with respiratory symptoms such as chronic cough, wheeze and recurrent pneumonia. 
Numerous tests are used in the diagnosis of GORD, however no single test is considered to be 
a gold standard test in the diagnosis of  chronic pulmonary aspiration. The tests used to 
diagnose GORD are:   
• Oesophageal pH test: An electrode probe is placed in the distal oesophagus 
where continuous recording the pH is performed. Scores less than pH 6.4 or 
3.7%.in the proximal oesophagus and pH 16.1 or 6.2% in the distal 




• Barium eosophogram: Barium in the form of an oral fluid is administered. 
Upper gastro-intestinal (UGI) aspiration is recorded if barium appears in the 
airway below the vocal cord. UGI direct is observed if aspiration occurs 
during swallowing and UGI reflux is observed if barium is found to move 
from the stomach to the oesophagus.  
• The lipid-laden macrophage index (LLMI): The presence of alveolar lipid 
laden macrophages in bronchoalveolar lavage fluid is considered to be a 
marker for lipid aspiration. Lipid stains such as the oil red O or Sudan black 




amount of lipid as reported by Corwin and Irwin et al
40











/4 opacified; 4= totally 
opacified.) a total of 100 macrophages are evaluated and a score ranging of 0-
400 is reported.  
Our laboratory routinely reports on the LLMI, however, it has been found in many studies 
that the number of lipid-laden macrophages has a low sensitivity for aspiration, and is often 
increased in pulmonary disorders unrelated to aspiration. The lipid-laden macrophage index 
thus cannot independently identify or exclude aspiration. A positive lipid-laden index over 
estimates the probability that a patient has GORD.
41,42
 Other studies investigating the lipid-
laden macrophage index in children, known with a history of GORD, had a median score of 
41.5% positivity compared to those who did not. Non-GORD children had scores of 12.5% 




Advances utilizing cow-milk protein specific immunocytochemical stains demonstrating 
aspiration in formula-fed infants have been explored. β-Lactoglobulin and α-lactalbumin 
cytoplasmic positivity in alveolar macrophages have been compared to the oil red O lipid 
laden macrophage index. α-Lactalbumin was more effective at demonstrating cow milk 
proteins associated with aspiration in formula-fed infants.
44
   
Pepsin, a gastric enzyme, is stored as pepsinogen in gastric chief cells. It is a protease 
digestive enzyme and when released by the chief cells in response to stimulation, is 
responsible for breaking down proteins into peptides. Literature suggests that the detection of 
pepsin in tracheal aspirates and BALF is more reliable in diagnosing GORD and 
microaspiration in children. Phillipe et al
 40
 used an immunoassay with rooster polyclonal 
antibodies to purified human pepsin to study pepsin as a marker in GORD-related pulmonary 
aspiration. Their finding revealed that pepsin-positive tracheal aspirates were more likely to 
have a clinical diagnosis of GORD, these children had either a history of chronic respiratory 
symptoms or both reflux coupled with chronic respiratory symptoms.
40
   
Another BALF pepsin study used an enzyme linked immunosorbent assay (ELISA) using 
monoclonal antibody to porcupine pepsin to detect pepsin in BALF of post lung transplant 
patients suffering from GORD. Their study revealed that the detection of pepsin in BALF of 







1.3.3 The hemosiderin-laden macrophage index in diffuse alveolar haemorrhage and 
haemosiderosis.  
Pulmonary alveolar macrophages process haemoglobin from phagocytosed erythrocytes to 
form ferritin. Haemosiderin is demonstrated in alveolar macrophages when stained with a 
ferrocyanide such as potassium ferrocyanide to form a blue compound. This is a simple 
diagnostic test performed on bronchoalveolar lavage fluid taken from infants and young 
children.  
The presence of haemosiderin-laden macrophages indicates the presence of haemosiderosis, 
idiopathic haemosiderosis or diffuse alveolar haemorrhage. These are serious and potentially 
fatal conditions in children and infants and the diagnosis is suggested by the presence of 
haematamesis; pulmonary infiltrates and the presence of haemosiderin laden macrophages.
46
  
Diffuse alveolar haemorrhage refers to a clinical syndrome characterized by extensive 
bleeding into the distal airways and alveoli as a result of microvascular injury. This may be 
associated with other underlying disorders such as infections and drugs such as penicillamine. 
Haemosiderin-laden macrophages only appear after 48 hours after the start of the bleed. The 
most commonly employed criterion aiding the diagnosis of diffuse alveolar haemorrhage is a 
haemosiderin-laden macrophage index score greater than or equal to 20% positivity.
47,48
  
Pulmonary haemosiderosis may be seen in association with cow-milk hypersensitivity, 
Goodpasture’s syndrome, aspiration of a sharp object or idiopathic. Salih et al 
49 
investigated 
the sensitivity and specificity of haemosiderin-laden macrophages in 6 children with a mean 
age of 4.36 year and a diagnosis of bronchitis, bronchiolitis or haemosiderosis. They were 
initially diagnosed with haemoptysis and 4 were diagnosed with pneumonia. Those that had 





1.3.4 The periodic acid-Schiff test in alveolar proteinosis and interstitial lung disease.  
Differential counts performed on bronchoalveolar lavage samples can be ineffective in 
conditions such as idiopathic pulmonary fibrosis, sarcoidosis and pulmonary alveolar 
proteinosis.   
Alveolar proteinosis is a condition characterized by the progressive filling of the alveoli by 




phospholipids by the type 2 pneumocytes and defective alveolar macrophage function from 
lamellar body ingestion. This condition may be idiopathic; related to immunosuppression, 
infection or as a result of chronic exposure to organic dust such as silica. Both extracellular 
and phagocytosed glycogen and phospholipoproteins contain high concentrations of 
carbohydrate macromolecules, which stain positively with the periodic acid-Schiff stain. This 
is seen as bright magenta pink staining proteinaceous material. A positive PAS may be used 
to assist in the diagnosis of alveolar proteinosis and confirm recurrence or persistence of this 
condition.
51,52
   
Although the stain is used predominantly in the diagnosis of alveolar proteinosis, one study 
demonstrates its usefulness in interstitial lung diseases. It revealed that known patients with 
sarcoidosis, idiopathic pulmonary fibrosis and extrinsic allergic alveolitis, demonstrated 




1.4 Cytological  preparation, processing  and interpretation
 of paediatric bronchoalveolar lavage fluid.  
  
  
1.4.1. Bronchoalveolar lavage fluid transport and processing.  
One of the recommendations described in literature is that BALF should be transported in 
containers that do not promote cellular adherence to the container’s surface such as glass or 
certain plastics. Most authors agree that BALF should be transported at room temperature 
(21ºC) if the transport to the laboratory and processing is less than 60 minutes as cells are not 
preserved well in saline. If transport is delayed resulting in processing after 60 minutes, the  
BALF can be stored at 4ºC for up to 24hours.
34,37,54
  
It has been suggested that the filtration of BALF through a loose nylon gauze may be a better 
technique when compared to cytocentrifugation as it yields fewer unsatisfactory specimens 
and traps large aggregates of mucin, although sputolysins may also be used.
2
 Various 
methods exist for processing and cellular quantification of BALF with regards to the 
differential count, lipid-laden macrophage index and haemosiderin-laden macrophage index. 
The cellular profiles of BALF may assist in determining the nature of the pulmonary disease. 




differential cell counts being performed on cytospin or cell smear preparations. This however 




 One such method for the initial preparation utilizes the filtration of pooled BALF through 
gauze; however, this may greatly diminish the volume of the sample, resulting in lower cell 
counts especially in macrophage. Ratjen et al 
35
used cell culture medium, Eagles minimum 
essential medium, to maintain the cells’ integrity after gauze filtration. BALF cell viability 
can be assessed using trypan blue staining when counting BALF leukocytes using a 
haemocytometer. Once quantified on a haemocytometer, BALF undergoes centrifugation at 
50-500rpm for 10-15 minutes for cell subtype differential counts on Diff-Quick
®
 stained 
slides using manual counts on simple smears. Lymphocyte, macrophages, neutrophils and 
eosinophils are ultimately expressed as a percentage per 100 cells counted in manual 
differential counts on BALF. More than one count is often performed and in a quest for 
maximum accuracy of differential cell count median percentages, some authors used a total of 
300-350 cells in their differential count whereas others used  a total of 600 cells per subject in 





1.4.2 Manual cell counts vs. electronic cell counts.  
Apart from the extensive time taken to perform manual counts on a haemocytometer, other 
sources of error described include:  
• Variations in the BALF sample haemocytometer loading volume  
• Haemocytometer chamber filling speed  
• Cell aggregates failing to enter the chamber  
• Cell distribution within the haemocytometer.  
The coulter counter, originally developed for counting blood cells, is an automated cell 
counting method which quantifies the number of cells within a conductive solution and 
determines their size when passed through a small orifice using changes in electrical 
conductance. The level of deflection is seen on a meter. This is the basis of modern day flow 




electronic cell counting to measure total cell numbers in BALF using an automated Coulter
® 
Counter D industrial model. The study revealed better reproducibility and faster results with 




1.4.3 Quantitation of the lipid-laden macrophage index and the haemosiderin-
laden macrophage index.  
Numerous studies employed the Golde score for the quantification haemosiderin-laden 
macrophages first described by Colombo and Hallberg for lipid-laden macrophages
42,47,59–63
 
where 200-300 alveolar macrophages were counted and graded 0-4 according to the amount 
of phagocytosed lipid/haemosiderin dividing the number of lipid/haemosiderin-laden 
macrophages by the total number of cells counted.  
• Grade 0 had no blue/red colour n the cytoplasm. (no opacification)  
• Grade 1 had faint blue/red cytoplasmic staining (1/4 opacification)   
• Grade 2 had either dense blue/red staining in a portion of the cytoplasm or   




/2 opacification)  
• Grade 3 had a deep blue/red staining throughout the cytoplasm. (1/2-3/4 
opacification)  








Figure 1.1: Colombo and Hallberg score for lipid laden macrophages. 
(https://ars.elscdn.com/content/image/1-s2.0-S0954611113004150-gr1.jpg)   
  
  








Chapter 2: Aim and study design
  
 
2.1 Aim.  
a) To determine if the BAL specimens can be used to categorize children with wheezing 
into either a gastro-eosophageal reflux or primary respiratory pathology group. 
Differential cells counts and counts of Oil red O positive lipid-laden macrophages, as a 
marker of the gastro-eosophageal reflux and pulmonary aspiration. Perl’s Prussian blue 
positive haemosiderin-laden macrophages for pulmonary haemosiderosis and carbon-
laden macrophages were used as marker of pulmonary pathology.  
b) To determine if BAL can assist with the sub-classification of the primary respiratory 
pathology group.  
c) To determine if the amount of phagocytosed carbon by alveolar macrophages 
corresponds to the patient’s environment of increased pollution and if these children 
have an increased risk for lung disease.  
2.2 Hypothesis.  
Alveolar fluid collected via the BAL technique is often abundantly cellular.  
a) The BAL cell counts will reliably distinguish the children that suffer from GERD from 
those who do not.  
2.3 Study design and case selection.  
  
This was a prospective study that enrolled consecutive, consenting patients who underwent a 
flexible bronchoscopy at Tygerberg Academic Hospital with BAL procedure for the workup 
of wheezing.   
Patients with cystic fibrosis and positive pulmonary tuberculosis infections where excluded.  
All samples were received in 12ml plastic test-tubes. A minimum of 2mls and maximum of 




provided by NHLS cytology; Tygerberg Hospital by cytotechnologists trained to process and 
perform paediatric BALF differential special stain cell counts. Samples were checked for 
adequacy by performing a routine haemocytometer count on unfiltered BALF. Samples with 
a total cell count of less than 50 cells/ml were rejected and not included in the statistical 
analysis in the study as there would have been too few cells present to perform differential 
cell counts and special stains. Adequate Samples were reviewed by cytotechnologist, Miss M. 
Marshall and pathologist, Professor P. Schubert.   
2.4 Diagnostic categories.  
After a full clinical work-up, the patients who originally presented either with a chronic 
wheeze, recurrent lower respiratory infection or both were given a final diagnosis. This 
was placed into 2 broad categories by the study’s collaborating senior paediatric 
pulmonologist at Tygerberg hospital, Professor P. Goussard. which were:   
• Recurrent wheeze.   
• Recurrent infection.  
These 2 broad categories of chronic wheeze and recurrent infection were further sub-divided 
into 6 sub-categories based on their final diagnosis after a full clinical workup. 
These sub-categories were: 
 Alveolar proteinosis 
 Gastro-oesophageal reflux disease 
 Idiopathic pulmonary haemosiderosis: 
 Infection/ inflammation These patients had a final outcome of either pulmonary 
tuberculosis; recurrent lower respiratory tract infection; pneumonia or bronchiolitis 
obliterans 
 Structural abnormality: These patients had a final outcome of either persistent right 
lower or middle lobe collapse; subglottic stenosis;  laryngomalacia;; bronchogenic 
cyst; innominate artery compression or vascular airway compression. 
  Idiopathic wheeze: These patients had no specific diagnosis after a full clinical 
investigation for their condition thus resulting in a final diagnosis of idiopathic 
recurrent wheeze. 
The patients in the study were categorised into main and sub-categories for the study to 




patients who presented with a recurrent wheeze could be placed into a pathological group and 
if the amount of environmental carbon significantly contributed to their condition in our 
setting based on literature. 
 




















Initial symptoms: Chronic wheezer/lower respiratory tract infection 
Main category based on final 
diagnosis: Infection/inflammation 
Main category based on 
final diagnosis: Wheezer 
Final diagnosis:  
 Alveolar proteinosis 
 Aspiration pneumonia 
 Bronchiectasis 
 Extrinsic tracheomalacia 
 Idiopathic pulmonary 
haemosiderosis 
 Interstitial lung disease 
 Pneumonia 
Final diagnosis:  
 Bronchogenic cyst 
 Bronchiolitis 
obliterans 
 Recurrent wheeze 
 Recurrent wheeze with 
atopy 
 Recurrent wheeze with 
GORD 
Sub-category based on final diagnosis: 
Structural abnormality                                GORD 
Infection /inflammation                Alveolar proteinosis 





Figure 2.1 Final diagnostic outcomes, diagnostic main categories and sub-categories. 
 
 
2.5 Laboratory investigations.  
  
The final clinical diagnosis was made after the entire workup was completed. The following 
tests were performed on the BALF and serum in this group of children to formulate a final 
outcome.  
  
Histological staining technique  
• Perl’s Prussian blue  
• Periodic acid-Schiff  
 
Cytology investigations: BALF specimen  
• Differential cell count  
• Carbon-laden macrophage quantification  
• Lipid laden macrophage index • Haemosiderin laden macrophage index  
• PAS positivity.  
 
MTB investigations: BALF specimen  
• GeneXpert MTB/RIF Ultra assay  
• Mycobacterium Tuberculosis culture.  





Microbiological investigations: BALF specimen  
• Gram stain.  
• Microbiological culture.  
 
Chemical investigations: Sweat and serum.  
• SWEAT test.  
• Serum IgA.  
• Serum IgG.  
• Serum IgM.  
 
Virology investigation of BALF:   
• Respiratory virus multiplex.  
• Cytomegalovirus  
Statistical analysis of the laboratory findings of the broad wheezer category will be compared 
against the broad categories of infection/inflammation, as well as the sub-categories of   
structural abnormality; GORD; infection/inflammation; idiopathic wheezer; alveolar 







Figure 2.2: Final diagnostic main category and sub-category comparisons of laboratory 
findings. 
  
2.6 Cytology differential count and special stain
 grading system.  
  
All processing of paediatric bronchoalveolar lavages was performed using a method 
developed by Dr CC Chase and her supervisor Professor D.J Roussouw at the University of 
Stellenbosch department of Anatomy and Histology. This method has been used at NHLS  
Cytology since 2007 at Tygerberg hospital.  (Appendix 1,22-24)  
Samples were checked for adequacy by performing a routine haemocytometer count on 
unfiltered BALF. Samples with a total cell count of less than 50 cells/ml were rejected as 














Broad category wheezer  
Laboratory findings  
Broad category infection/inflammation  V 
Sub-category idiopathic wheezer  V 
Sub-category idiopathic wheezer   
Alveolar proteinosis  






Adequate samples were processed for differential cell counts, lipid-laden macrophage 
index(LLMI), haemosiderin-laden macrophage index (HLMI) and carbon-laden macrophages 
(CLM) and quantified accordingly.  
2.7 Ethical approval.  
Ethical approval was obtained from the Health Research Ethics Committee, Stellenbosch 
University. Project ID 2517 (S16/08/148).  






Chapter 3: Materials and methods  
 
3.1 Paediatric bronchoalveolar lavage fluid collection.  
 Flexible bronchoscopy and collection of BALF was performed by the division of paediatric 
pulmonology, Department of Paediatrics and Child Health, Tygerberg Hospital, Stellenbosch 
University, under the guidance of Professor P. Goussard.   
The bronchoalveolar lavage fluid was obtained by using 10-20ml aliquots of sterile saline 
warmed to body temperature (37-38ºC) and lavaging the distal airspaces before re-aspirating 
the fluid as per the ERS task force guidelines for bronchoalveolar lavage in children.
64
  The 
instilled fractions will be retrieved and pooled in a 12ml plastic test-tube and sent to the 
cytology department for routine cytological analysis.  
  
3.2 Cytology processing of bronchoalveolar lavage
 fluid.  
We have been processing paediatric bronchoalveolar lavages since 2007 as per the method 
pioneered by Professor D.J Roussouw and Dr. CC Chase and her supervisor at Stellenbosch 
University, Department of Anatomy and Histology. Unstained leukocytes in unfiltered BALF 
are manually counted in a haemocytometer to check for adequacy and necessary dilution if 
required. Cytospin slides are then prepared and slides are stained using the Papanicolaou; 
Giemsa; Oil red O in cytology. Cytospin slides destined to be stained for haemosiderin and 
glycoproteins are performed by histology. Differential cell counts, lipid laden macrophages 
and haemosiderin-laden macrophages are then quantitated and reported accordingly. Their 
work was never published; however, her method was presented the 37th Annual Conference 































Adequate: >50 cells 
Cytospin slides prepared 
 1 Papanicolou 
 1 Giemsa 
 Differential count 
 Carbon-laden macrophage 
count 









 Periodic acid-schiff 
Periodic acid-schiff  
for glycogen 
positive/ negative 





3.2.1  Specimen adequacy and haemocytometer manual cell counts. 
The entire counting chamber of a haemocytometer is 3 x 3mm with a depth of 0.1mm 
(Appendix 22). The area of the counting chamber is therefore 9mm
2 
with a depth of 0.1mm. 
When converting the number of cells to volume per ml after counting a full chamber, the 
average of the 2 counts are multiplied by 0.9 (area x depth) and multiplied by 1000 (10
3
) to 
express the cell quantity per ml. The same applies to a half chamber count in a slightly more 
cellular smear, with the exception of using half of the aforementioned area but still keeping 
the chamber depth unchanged. If there is a very cellular specimen, only the central 25 squares 
are counted. The central 25 square has an area of 1 x1mm, the total number of cells therefore 
counted in the central 25 squares must be divided by 0.1 to get the total number of cells per 
ml.  
If using a hypothetical average cell count of 50 as an example used in each chamber count, 
the calculations would be explained as follows:  
• Full chamber:  
Cells/ml=       Average amount of cells counted   
                     Chamber depth x chamber area  
           =                      50  
 
                          0.1 x 3 x 3mm  
           =                        50  
 
                                     0.9mm3    
           =               55.56x10
3
 cells/ml  
• Half chamber:  
Cells/ml=       Average amount of cells counted   
                     Chamber depth x chamber area  
           =                      50  
 




           =                        50  
 
                                     0.45mm
3
    
          =                111.11x10
3
 cells/ml  
• Central 25 squares  
Cells/ml=       Average amount of cells counted   
                     Chamber depth x chamber area  
           =                      50  
 
                          0.1 x 1 x 1mm  
           =                        50  
 
                                     0.1mm3    
          =              500x10
3
 cells/ml  
More cells require less volume of BALF when making cytospin smear. In addition, 
depending on the total cellularity, appropriate dilutions are required to be made in order 
to achieve an even distribution of cells on the cytospin.  
  







Method:   
1) BAL laboratory number and volume was measured and recorded in a BAL book  
2) A small amount of unfiltered BALF was decanted into a separate tube if specimen 
was more than 8ml.  
3) Two separate cell counts were performed on unfiltered BALF if less than 8ml on a 
haemocytometer as follows.   
• Macrophages (granulocytes were counted with macrophages), lymphocytes, red blood 
cells and columnar epithelial cells were counted.  
• Full chamber: If there are 1-2 cells per square (or fewer) in the haemocytometer, 
excluding red blood cells and epithelial cells. All 169 squares were counted, divided 
by 0.9 and multiplied by 10
3
.   
• Half chamber: If there were more cells, fewer squares were counted. The total 
macrophage and lymphocyte count was at 100, fewer cells were counted. The count 
would start at the middle line and the result was divided by 0.45 and multiplied by10
3
.  
• Central 25:  If the sample was too cellular, only the central 25 squares were counted.  
The result was multiplied by 10 x10
3
  
4) The specimen was fixed with an equal volume of BAL suspension and histological 
phosphate buffered formalin as follows:   
  
  







Table 3.1: Manual haemocytometer count requiring no dilution.  
Unfixed: Cells/ml (x103) Fixed: cells/ml(x x103))
 Drops  µl   
    Papers smears  
 
Before Fixation  After fixation          
  1-24   14  -    4  
50-60  25-30  14   434  2  2  
60-80  30-40  13  403  2  2  
80-100   40-50  11  341  2  2  
100-120  50-60  9  279  2  2  
120-160  60-80  7  217  2  2  
160-240  80-120       5  155       1       2  
240-300  120-150  4  124  1  2  
300-380  150-190  3  95  1  2  
380-440   190-220  2  90  1  2 Samples with these cell counts are fixed 
with equal volumes of BALF and buffered   formalin.  
s Samples with 1-24x103(very low counts): take 8m filtered BALF, add 2ml formalin.  
 
Source: Dr CC Chase, department of Anatomy and Histology, University of Stellenbosch. 2 Oct 2007.  
  
 
 Table 3.2: Manual haemocytometer count requiring a 4x dilution.  
440000-880000 cells/ml: dilute with normal saline.  
Unfixed: Cells/ml (x103) Fixed: cells/ml(x x103))
 Drops     
   µl   
    Papers  
   smears  
 
Before Fixation  After fixation            
440-460  110-115  5  155  1                 2  
460-600  115-150  4  124  1                 2  
600-740   150-185  3  95  1                 2  
740-880  185-220  2  90  1                 2  




Source: Dr CC Chase, department of Anatomy and Histology, University of Stellenbosch. 2 Oct 2007. Table  
3.3: Manual haemocytometer count requiring a 8x dilution.  
880000-2000000 cells/ml: dilute with normal saline as follows:  
Unfixed: Cells/ml (x103) Fixed: cells/ml(x x103))
 Drops  µl   
    Papers smears  
 













920-1200  115-150  4  124  1  2  
1200-1600  150-200  3  95  1  2  
2000-2400  200-300  2  90  1  2  
8x Dilution using 3ml saline+4ml formalin+1ml BAL      





: 280µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl  
4000x10
3
: 200µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl  
5000x10
3
: 160µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl  
6000x10
3
: 133µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl  
7000x10
3
: 144µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl  
8000x10
3
: 100µl BAL+ 2ml saline+ 2ml formalin (mixed before adding BALF). Use 90 µl If 
fixed cells can’t be counted, there should be about 200x10
3
 per ml in the entire chamber.  
5) Unfixed BALF with a total cell count of <50 in the haemocytometer were rejected as 
too few cells would be present to perform the differential count and special stains.  
6) Fixed BAL was allowed to stand for 10 minutes at room temperature.  





8) If, however, the total count could not be performed on the same day, the specimen 
was fixed with equal volume of buffered formalin and stored in the refrigerator. 
Dilutions, if required were then performed on the fixed specimen  
  
3.2.2 Cytocentrifuge slide preparation  
Method:  
1) The laboratory tracking number, name and stain was written on the 
slide.  
2) The cytospin apparatus was assembled in a biosafety cabinet by placing 
the slide, plastic funnel and relevant number of filter cards in the 
cytospin holder ensuring that the holes in the filter card and plastic 
funnel coincide at the back of the cytospin holder and ensuring that the 
filter paper has it’s indentations facing upwards.  
3) The fixed BAL specimen was re-suspended using a 3ml plastic pipette.  
4) The recorded volume of BAL fluid was pipetted into the funnel.  
5) The cytospin bucket was loaded, balanced, sealed and placed into the 
cytocentrifuge.  
6) The centrifuge was set to spin for 7 minutes at 1350rpm.  
7) Once centrifugation was completed, the cytospin bucket was removed 
from the cytocentrifuge and returned to the biosafety cabinet.  
8) Cytospin apparatus was disassembled and the slides were allowed to dry 
before being stained with the Papanicolaou; Rapid-Diff; Oil-red O; 
Perl’s Prussian blue and periodic acid-Schiff stains.  





Figure 3.4: (a)Cytospin apparatus unassembled. (b)Cytospin apparatus assembled with 
coinciding filter and funnel holes.   
  
3.2.3 Papanicolaou staining technique.   
The Papanicolaou staining method is a polychromatic staining reaction used to display 
cellular morphology by demonstrating various degrees of cellular maturity, metabolic activity 
and the variations thereof on spray-fixed slides. The staining method consists of a nuclear 
stain and 2 cytoplasmic counterstains. Hydration prepares the cells to take up nuclear stain 
and dehydration prepares the cell to take up the counterstains. One of 2 methods can be used 
when staining cells with the Papanicolaou stain. The first is the progressive method where the 
nucleus of the cell is stained with haematoxylin, the nuclear dye, until the desired staining 
intensity is achieved and a blueing agent such as lithium carbonate is placed shortly after the 
haematoxylin step to allow the nuclear stain to set without tinting the cytoplasm. The other 
method is the regressive method where the nucleus is overstained with a non-acidified 
haematoxylin and a dilute solution of hydrochloric acid (HCL) is placed after the nuclear 
stain step thus removing excess haematoxylin. The cells are briefly exposed to this 
decolourising acid and then rinsed in water to prevent hypochromasia. The aluminium 
sulphate in the dye ensures that haematin the haematin can bind to the phosphoric groups on 
the DNA chain by supplying positively charged ions.  OG or Orange G is an acidic dye used 
to stain keratin intensely orange. The stain is also taken up by the eosinophilic granules in 
superficial cells. EA is a polychrome stain and is the combination of light green SF yellowish 
and eosin Y. The light green SF yellowish is an acidic dye which is involved in staining the 











columnar cells.  Eosin Y is also acidic and is responsible for staining cilia, erythrocytes, 
nucleoli and the cytoplasm of superficial squamous cells.
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The staining method employed in our laboratory is regressive. Harris haematoxylin, EA-50,  
OG II,32% hydrochloric acid (HCL), lithium carbonate (LiCO3) , methanol, Rapidiff 1 and  
Rapidiff 2 are commercially obtained for routine laboratory use. (Appendix 2)  
A lithium carbonate saturated stock solution is prepared by dissolving commercially bought 
pure LiCO3 tablets in distilled water, the supernatant is used to make up the working solution.  
Working solutions are prepared for use in the Papanicolaou staining method, namely the 
hydrochloric acid (HCL) working solution and Li2CO3working solution.   
Results:  
Nuclei:  Basophilic  
Cytoplasm:   
• Superficial cells: Eosinophilic  
• Intermediate cells: Cyanophilic/Eosinophilic  
• Columnar and non-epithelial cells: Cyanophilic  






3.2.4  Giemsa staining technique.  
The Giemsa stain is a staining procedure performed on air-dried slides. The Rapi-Diff stain is 
the modified rapid version of the giemsa stain. Both require fixation in methanol as the initial 
step to prevent cells from having flat nuclear patterns which may pose diagnostic difficulties. 
A useful stain used in the demonstration of non-epithelial components such as myxomatous 
material, mucin, amyloid and colloid or where haematological disorders may be suspected. 
(Appendix 3)  
Results:  
• Nuclei: Purple  
• Cytoplasm: Pink/blue  
• Eosinophils: Pink/red  
• Mucin/amyloid/myxomatous material: Bright pink.  
  
3.2.5  Oil red O staining technique.  
The Oil red O stain is used to demonstrate the accumulation of  lipid. (Appendix 4)  
Result:   
• Nuclei appear blue.   
• Lipid appears red.66   
3.3 Histological staining techniques  
  
3.3.1  Perl’s Prussian blue staining technique.  
Haemosiderin is the protein compound by-product of degraded haemoglobin and is normally 
seen intracellularly as yellow to brown granules. Haemoglobin is insoluble in alkalis but 
soluble in acid solutions. Treatment with an acid ferrocyanide solution results in the 
unmasking of ferric iron as an hydroxide, Fe(OH)3 by diluted hydrochloric acid. The ferric 
iron subsequently reacts with a diluted potassium ferrocyanide solution to produce an 




Result: .Nuclei appears red. Haemosiderin appears blue.
66
   
 
3.3.2  Periodic Acid-Schiff staining technique.  
The Periodic acid-Schiff is one of the most widely used histological staining techniques used 
for the demonstration of carbohydrates and glycoconjugates. Carbohydrates contain free 
aldehyde groups which react with Schiff reagent to form a magenta-coloured compound. The 
intensity of the reaction depends to some extent on the length of the treatment in with the 
periodic and Schiff’s solutions. (Appendix 6)  




3.4 Cytology differential counts and special stain
 quantitation.  
  
Various cell counts were performed and recorded on a differential cell count and special stain 
quantitation form (Appendix 7). All cell counts were performed on the Olympus BX43 
microscope using the 40x objective lens.  
  
3.4.1 Differential cell counts   
A differential count was performed on the white blood cells. 2 separate counts of 100 cells 
each were counted on the Papanicolaou and Rapidiff Giemsa stained slides.  
Method:  
1) The number of macrophages, neutrophils, lymphocytes and eosinophils were 
quantified using a white blood cell differential cell tally counter.  
2) Two separate counts of 100 cells each were performed.  






Figure 3.5: (a) Papanicolaou stained slide for differential cell counts. (b) Giemsa stained 
slide for differential cell counts.  
  
3.4.2 Alveolar macrophage quantitation for lipid, haemosiderin and carbon.  
Only macrophages larger than a granulocyte were counted on the same white blood cell 
counter. The first through to fourth knobs were used to count class I-IV alveolar macrophages 
respectively. Class III and IV carbon-laden macrophages were not expected, nor were they 
found.   
  
Method:   
1) The macrophages were classified as follows:  
• I: Negative for cytoplasmic lipid/haemosiderin/carbon black  
• II: approximately 1/4 but less than 2/4 of the macrophage contained 
phagocytosed lipid/haemosiderin/carbon black.  
• III:  approximately 3/4 of the macrophage contained phagocytosed 
lipid/haemosiderin/carbon black however negative spaces can still be seen. 
• IV: The cytoplasm is almost full or entirely full of lipid/haemosiderin/carbon 
black  
2) Two counts of 100 macrophages were performed.  
3) The average was taken of each class count and multiplied as follows to obtain a 
percentage (x-factor)  
• Class 1: Multiply by 0  
 
    




• Class II: Multiply by 0.3  
• Class III: Multiply by 0.6  
• Class IV: Multiply by 1  
4) The sum of each class x-factor was reported as a percentage.  
  
 
Figure 3.6: (a) Class I LLM. (b) Class II LLM. (c) Class III LLM. (d) Class IV LLM.  
 
Figure 3.7: (a) Class I HLM. (b) Class II HLM. (c) Class III HLM. (d) Class IV HLM.  
    














Figure 3.8 (a) Class I CLM. (b) Class II CLM.  
  
3.4.3  Periodic acid-Schiff. 
PAS positive macrophages were not quantified. If intracellular glycogen was seen, the PAS 
was either reported as positive or negative.  
  
 
Figure 3.9: (a) PAS negative alveolar macrophage. (b) PAS positive alveolar 
macrophage.  
  
3.5 Pulmonary tuberculosis investigations  
  
3.5.1 GeneXpert.  
GeneXpert
®
 MTB/RIF is an automated, polymerase chain reaction cartridge based nucleic 
acid amplification assay used for the detection of Mycobacterium tuberculosis and rifampicin 
resistance by targeting the rBop gene of the mycobacterium.
67
 (Appendix 8)   
 
Result: If no growth is detected, a result of Negative for MTB complex will be given.  
         a b 





3.5.2 TB culture.  
More acid-fast bacilli are required for visualization in direct microscopy in comparison to 
culture. Specimens sent for mycobacterial culture are either pulmonary in origin or extra-
pulmonary and can be  sorted into contaminated or non-contaminated. Contaminated samples, 
such as those of pulmonary origin undergo decontamination to eliminate bacteria other than 
mycobacteria with Sodium Hydroxde-N-Acetyl-L-Cysteine as per MGIT automation culture 
system recommendation. After processing, specimens are inoculated into a MGIT tube and 
entered into the BACTEC MGIT 960 System. A fluorescent compound embedded in the 
silicone on the bottom of the MGIT tube fluoresces when respiring micro-organisms consume 
oxygen. (Appendix 9)  
Result: As per Tygerberg hospital, NHLS TB culture laboratory specific SOP, If no growth 
occurs, a result of “No growth after 40 days” will be given. If positive, the HAIN PCR is run 
as per manufacturer’s instructions (Appendix 10). 
  
3.5.3 Auramine O staining procedure and reporting.  
Acid fast organisms emit a distinct bright yellow fluorescence with the potassium 
permanganate counter stain. Positive fluorescent acid-fast bacilli are seen slightly curved rod-
shaped micro-organisms. (Appendix 11)  
3.6 Microbiological investigations  
  
3.6.1 Bronchoalveolar lavage fluid gram stain   
The gram stain is used to classify bacteria based on their size; shape and cellular morphology. 
Bacteria stain either Gram-positive or gram negative based on architecture and composition 
of their cell wall. Gram-positive bacteria have a thick peptidoglycan layer and thus retain 
their initial deep violet stain as they are unaffected by alcohol decolourisation. Gram-negative 
bacteria have a single peptidoglycan layer and is decolourised by alcohol, allowing the 
microorganism to be stained by counterstains. (Appendix 12)  





3.6.2 Bronchoalveolar lavage fluid microbiology culture.  
Microbiological culture of sputum samples are ineffective at determining whether a pathogen 
is causing a lower or upper respiratory tract infection 
70
.  A gram stain is performed on BALF 
to detect the presence of active inflammation in the lower respiratory tract as well as assist in 
determining the most likely organism. Specimen is used to inoculate various culture plates.
68
 
(Appendix 13)  
3.7 Chemical pathology investigations  
  
3.7.1 Sweat test. 
Chloride is one of the sweat electrolytes increased in patients suffering from cystic fibrosis. 
Pilocarpine is a drug that stimulates the sweat glands to enable for an adequate sweat sample 
collection. Iontophoresis is performed whereby positively charged pilocarpine ions are moved 
into the skin between 2 electrodes whilst current is being passed. The sweat is collected on 
pre-weighted filter paper and extracted (Appendix 14). Extracted chloride is then analyzed as 
per manufacturer’s instructions (Appendix 15). This test can be performed on normally 
hydrated infants, 2 weeks of age and weighing more than 3kgs without significant systemic 
illness according to NHLS Tygerberg chemical pathology laboratory subject suitability..   
Results:   
• <40mmol/l:   Cystic fibrosis is unlikely  
• 40-59mmol/l: Suggestive of cystic fibrosis but not diagnostic.  






3.7.2 Serum Ig A.  
Ig A is the predominant immunoglobulin in bodily secretions such as sweat and saliva. It 
serves to protect the skin and mucosa against micro-organisms by binding to toxins and in 
conjunction with lysozyme, results in anti-bacterial and antiviral activity. Increased IgA 
levels are seen in chronic infections and sarcoidosis, whilst decreased IgA levels are seen in 
acquired and congenital immunodeficiency diseases. IgA assays are used to determine serum 
and plasma IgA levels.   
The IgA assay is an immunoturbimetric assay in which anti-IgA antibodies react with the IgA 
antigen in the sample to agglutinate and form an antigen-antibody complex. The aggregates 
are determined turbidimetrically. (Appendix 16)  
  
3.7.3 Serum Ig G.  
IgG is a maternal immunoglobulin that can cross the placental barrier and provide passive 
immune protection to a foetus. The main role of IgG is to provide defence against 
microorganisms by directly neutralizing a toxin via an induction of complement fixation. IgG 
level gradually decline as the infant’s own immunological system develops. Increased IgG 
levels are seen in infectious diseases and cystic fibrosis.   
The IgG assay is an immunoturbimetric assay in which anti-IgG antibodies react with the IgG 
antigen in the sample to agglutinate and form an antigen-antibody complex. The aggregates 
are determined turbidimetrically. (Appendix 17)  
  
3.7.4 Serum Ig M.  
IgM is the first immunoglobulin to appear in the serum after an infection. It aids in the killing 
of bacteria by activating complement. Unlike IgG, the IgM serum levels decrease rapidly 
once the infection has cleared and allows for the differential diagnosis when comparing the 
two antibodies. Increased IgM levels are found in infections (viral; bacterial and parasitic), 
cystic fibrosis and heroin addiction. IgM levels are generally lower in infants due to the slow 




The IgM assay is an immunoturbimetric assay in which anti-IgM antibodies react with the 
IgM antigen in the sample to agglutinate and form an antigen-antibody complex. The 
aggregates are determined turbidimetrically. (Appendix 18)  
  
3.7.5 C-Reactive Protein.  
C-reactive protein is an acute phase protein found in inflammatory reactions and is 
synthesized by the liver. CRP assays are used to detect systemic inflammatory responses. The 
test involves a particle enhanced immunoturbimetric assay where human CRP agglutinates 
with latex particles coated with monoclonal anti-CRP antibodies. The aggregates are 
determined turbidimetrically.  (Appendix 19)  
3.8 Virology investigations  
  
The basic principle of polymerase chain reaction (PCR) is that one DNA molecule is used to 
produce exponential copies. DNA is made up of 4 nitrogenous bases, namely adenine (A), 
thymine (T), cytosine (C) and guanine (G). This continuous doubling is achieved by using 
specific proteins called polymerases, which are enzymes that can string together individual 
DNA bases to form long strands.  These polymerases require a primer which is DNA 
fragments that bind to the bases. A target DNA molecule that serves as a template.  
  
3.8.1 Respiratory virus multiplex   
The Anyplex® II RV16 PCR system is a qualitative multiplex real-time polymerase chain 
reaction system using TOCE™ technology which allows for the detection of multiple 
pathogens from respiratory tract (nasopharyngeal aspirate, nasopharyngeal swab and 
bronchoalveolar lavage) specimens in a single fluorescence channel on real-time PCR 
instruments. Multiple amplifications of target RNA/DNA for 16 viruses in 2 panels can 
therefore be performed. The viruses detected are Influenza A virus, Influenza B virus, Human 
respiratory syncytial virus A, Human respiratory syncytial virus B, Human adenovirus, 
Human metapneumo virus, Human coronavirus 229E, human coronavirus NL63, Human 




parainfluenza virus 4, Human rhinovirus A/B/C, Human enterovirus and Human bocavirus 
1/2/3/4. (Appendix 20)  
  
3.8.2 Cytomegalovirus  
Cytomegalovirus (CMV) is a DNA virus from the family Herpesviridae. It affects humans of 
all ages and has no seasonal or epidemic patterns of transmission. The bulk of CMV 
infections are asymptomatic, however may become a life-threatening disseminated disease in 






Chapter 4: Results   
 
4.1 Mean age in months.  
The study has a total of 90 patients in the category of “chronic wheeze”. 23 Samples were 
rejected due to poor cellularity and age exclusion. Of the 67 patients with BALF adequate for 
evaluation, 27 were female and 40 were male. Of these 67 patients, the mean age was 20.88 
months. The youngest patient, both male and female, was 3 months of age and eldest was 60 
months old.  
The broad category final outcome diagnosis of infection/ inflammation (n=36) had a mean 
age of 22.92 months compared to the recurrent wheezer (n=31) who were slightly younger 
and had a mean age of 18.52 months.    
When comparing the sub-categories, older children with a mean age of 24.95 months were 
found to have infection/inflammation (n=23), compared to recurrent wheeze (n=13) who had 
a mean age of 18.45 months; GORD (n=9) had a mean age of 15.54 months; structural 
abnormalities (n=14) had a mean age of 14.57 months; IPF (n=1)  was 13 months and 
alveolar proteinosis (n=1) was 14 months. Six were initially lost to follow-up but later were 
placed in the broad category of recurrent wheeze and recurrent infection.  
  
  





Figure 4.2: Sub-category age in months comparison.  
  
4.2 Cytology cell count results.  
  
4.2.1 Differential cell count results.  
The 2 isolated cases of alveolar proteinosis and idiopathic pulmonary haemosiderosis were 
added to the inflammation/infection category the sub-category differential counts.  
The 2 sample t-test with equal variances, also known as a mean comparison test, was applied 
to see if the differential cell count means of the 2 populations of “recurrent infection” vs 
“recurrent wheeze” were equal.  
 
The results of the compared means for the different cell types in the BALF for the 2 broad 
categories were as follows:  
Table 4.1: Main category comparison of differential cell counts.  
Category  Mean  
Macrophage %  
Mean   
Neutrophil %  
Mean  
Lymphocyte %  
Mean   
Eosinophil %  
Recurrent 
infection  
27  60  12  0.7  
Recurrent 
wheeze  
32  53  13  
0.8  
Significance  Pr(|T| > |t|) = 
0.3600  
Pr(|T| > |t|) = 
0.3426  
Pr(|T| > |t|) 
= 0. 7852  
Pr(|T| > |t|)  





Figure 4.3: Main category differential cell count comparison.  
  
There was a fairly even split when comparing the mean differential cell counts of the 




Figure 4.4: Sub-category differential cell counts comparisons.  
When comparing the broad categories, recurrent wheeze had a  mean macrophage score of 
32% compared to recurrent infection which had a mean macrophage score of 27%. The mean 

















60% in recurrent infection. There was a 1% difference in the lymphocyte score with recurrent 
wheeze having a mean lymphocyte score of 13% vs that of the 12% mean lymphocyte score 
seen in recurrent infection. Similarly, the mean eosinophil score was 0.8% in recurrent 
wheeze and 0.7% in recurrent infection. There was no statistically significant difference 
between the means of the macrophages, neutrophils, lymphocytes or eosinophils of the 2 
broad groups of recurrent infection vs recurrent wheezer. When comparing the differential 
cell count cell profiles between the various sub categories, the chronic wheezer had the 
highest mean macrophage score of 40.46% followed by GORD which had a mean 
macrophage score of 33.07%. The structural abnormality and infection/inflammation sub-
category shared a very similar lower mean macrophage score with structural abnormality 
scoring 22.12% and infection/inflammation scoring 23.37%. There was no statistically 
significant difference between the means of the macrophages, neutrophils, lymphocytes and 
eosinophils when comparing the sub-categories against each other. 
4.2.2 Carbon, lipid and haemosiderin-laden macrophage results.  
A median regression and 2 sample t-test with equal variances was performed on the 2 main 
groups comparing the mean carbon, lipid and haemosiderin counts of the 2 groups.   
  
 Table 4.2: Main category comparison of carbon, oil red O and haemosiderin variables.   
Category  Mean carbon-laden 
macrophage %  
Mean lipid-laden 
macrophage %  
Mean  
haemosiderin laden 
macrophage %  
Recurrent 
infection  
4.718571  8.499444  8.900571  
Recurrent 
wheeze  
6.258064  6.496774  5.883226  
Significance  
  







Figure 4. 5: (a) Main category comparison of ORO variable. (b) Main category comparison 
of Perl’s variable. (c) Main category comparison of carbon variable.  
There was no statistically significant difference between the means of the lipid-laden, 
haemosiderin-laden or carbon laden macrophages of the 2 broad groups of recurrent infection 
vs. recurrent wheeze.  
Next, the sub-groups were compared.   
  
Table 4.3: Sub-category comparison of carbon ORO and haemosiderin variables.  
Category  Mean carbon-laden 
macrophage %  
Mean lipid-laden 
macrophage %  





6.605556  3.094444  2.727778  
Idiopathic 
wheeze  
7.984615  7.288461  9.040769  
Infection/ 
inflammation  
4.780435  12.66652  4.630435  
Structural 
abnormality  
3.557143  5.721429  10.52846  
  
Single values as with IPF and alveolar proteinosis are indicated as a single line due to only 
one case of each being present. Only 1 patient had a final outcome of alveolar proteinosis 






Figure 4.6: (a) Sub-category comparison of ORO variable. (b) Sub-category comparison of 
Perl’s variable. (c) Sub-category comparison of carbon variable.  
GORD was used as the reference as it showed the least amount of both lipid-laden and 
haemosiderin-laden macrophages.  
The infection/inflammation sub-group showed the highest number of lipid-laden 
macrophages with a p50 value of 6.55. The idiopathic wheezer sub-group showed the highest 
number of carbon-laden macrophages and haemosiderin-laden macrophages.  
  
  
When comparing the other 3 categories, using GORD as the constant. Carbon had the highest 
value in the wheezer category and overall, it was not considered to be significant.  
  
Table 4.4: Sub-category comparison of carbon, lipid and haemosiderin against a constant 
(GORD).  
Category  Mean carbon-laden 
macrophage %  
Mean lipid-laden 
macrophage %  











2.484722  3.473902  2.128534  
Structural 
abnormality  
0.3291669  3.169685  1.942519  
Age in months  
  .0680556  .085515  .0517723  
Cons(GORD)  
  
2.0875  2.703297  1.696885  
Significance  Prob > F = 0.4382  Prob > F =    0.2848  
  
Prob > F =    0.1126  
   
  
Age adjustment allowed for the distribution ages of the patients in the study to be compared 
as variables. In the case of haemosiderin-laden macrophages, it revealed that GORD patients 
were younger (<20months) and had a lower haemosiderin-laden macrophage index than that 
of the infection/inflammation sub-category who had a wider age range and a higher 











4.2.3 Periodic acid-schiff  results.  
The single case of alveolar proteinosis was PAS positive. A total number of 49 PAS positive 
results were reported in this study.  
  
4.3  Pulmonary  tuberculosis investigations results.  
  
There were a total of 2 cases with trace and intermediate MTB complex detected, these 
however all had a negative culture and Auramine O result.  
Barring the 2 aforementioned results, the following results were reported on the BALF of the 
patients involved in this study:  
• TB culture:      Negative (no growth after 40 days).  
• GeneXpert® MTB/RIF:  Negative MTB complex not detected.  
• Auramine O:     Negative.  
  
  
4.4 Microbiology investigations results.  
  
4.4.1 Gram stain results  
  
In the 2 broad category groups’, gram stain results were compared against one another, it was 
found they shared very similar results, however, the recurrent wheezer had a slightly higher 
number of neutrophils with no bacteria observed on their BALF gram stain with no growth 
after 2 days.  
7 out of the 9 cases of the recurrent wheezer revealed a negative gram stain result consisting  
of neutrophils and no bacteria and no bacterial growthseen on the culture of their BALF.   
Table 4.5: Main category recurrent wheezer and recurrent infection gram stain comparison.  




Wheezer  9 (n) 13 (n) 6 (n) 3(n)  
Infection/ 
inflammation  
10 (n) 11 (n) 6 (n) 3 (n) 






Figure 4.8: Microbiology gram stain results comparison between recurrent wheezer and 
recurrent infection.  
 
4.4.2 Culture results  
  
When BALF culture results were compared against one another in the 2 broad category 
groups’, they shared very similar results. A greater variety of species were cultured from the 
BALF of the recurrent infection category than that of the recurrent wheezer category.  
  
 
Table 4.6:  Main category recurrent wheezer and recurrent infection BALF microbiology 
culture sample outcome comparison.  
Category  







Wheezer  (n)16  (n)5  (n)8  (n)2  
Infection/ 
inflammation  
(n)15  (n)6  (n)7  (n)7  
   
Table 4.7:  Main category recurrent wheezer and recurrent infection BALF microbiology 






Recurrent wheezer  Recurrent infection  
• Normal flora isolated (5 ) 
• H. Influenza (4 ) 
• Klebsiella pneumoniae(1) 
• Streptococcus pneumonia (4 ) 
  
• Normal flora isolated (7 ) 
• H. influenza(4 )  
• M.Catarrhalis (1 ) 
• Klebsiella oxytoca ( 1) 
• Streptococcus pneumonia ( 1) 







4.5 Chemical pathologyinvestigation results.  
  
4.5.1 Sweat test.  
Out of 43 sweat tests requested in total, 39 were negative and indicated that cystic fibrosis 
was unlikely. There were 4 reports that had an intermediate report for cystic fibrosis 
indicating that cystic fibrosis may be possible. 2 were from the recurrent wheeze category and 
2 were from the recurrent infection category. There was no final diagnosis of cystic fibrosis 
those 4 cases.  
4.5.2 IgM.  
The IgM variable was initially compared in the 2 broad categories of chronic wheezer and 
recurrent infection. The IgM in the recurrent infection category was slightly higher than that 
of the recurrent wheeze category; however it was not statistically significant.  
When the IgM variable was then compared in the sub-categories, it was highest in the 
idiopathic wheezers and more normal in the inflammation, structural abnormality and GORD 







Table 4.8:  Main category IgM comparison.         

























Table 4.9:  Sub-category IgM comparison.  






































































4.5.3 IgG.  
  
The IgG variable was compared between the broad category chronic wheezer and recurrent 
infection. The IgG in the recurrent infection category almost double that of the recurrent 
wheeze category, however it was not statistically significant.  
When the IgG variable was then compared in the sub-categories, it was similarly elevated in 
the infection/inflammation; wheezer and structural abnormality categories, with a higher 
normal distribution in GORD. This however was not statistically significant.  
Table 4.10: Main category IgG comparison.          






















Table 4.11:  Sub-category IgG comparison.  
Category  
Hi IgG  Low IgG  









































































 4.5.4 IgA.  
The IgA variable was compared between the broad category chronic wheezer and recurrent 
infection. Although the IgA distribution was higher in the recurrent infection when compared 
to the recurrent wheeze category, it was not statistically significant.  
The IgA variable was fairly similar when compared between the various sub-categories. No 
statistical significance was found.  
Table 4.12: Main category and sub-category IgA comparison.   





















Significance  Pearson chi2(3) =   4.1590   Pr = 0.245    
  
  
Table 4.13:  Sub-category IgA comparison.  
  
Category  
Hi IgA  Low IgA  










































































4.5.5 C-reactive protein (CRP).  
When comparing the C-reactive protein variable against the various sub-categories, it was 
highest in the inflammation and infection category and fairly evenly distributed amongst the 
wheezer, GORD and structural sub-categories. This however, was not statistically significant.  
Table 4.14:  Sub-category C-reactive protein comparison.  
Category  
Hi CRP  

























































4.6 Virology investigations   
  
4.6.1 Respiratory virus multiplex comparison outcome between recurrent wheeze vs. 
infection.  
When the 2 broad category groups’ virology results were compared against one another, it 
was found there was more viral species isolated in the recurrent wheezer category than in the 






Table 4.15:  Broad category wheezer virology respiratory virus multiplex comparison.  
Recurrent wheezer  Recurrent infection  
• Adenovirus (11) 
• Coronavirus OC43 (3) 
• Coronavirus OC63 (1) 
• Enterovirus (4) 
• Human rhinovirus (17) 
• Human metapneumovirus (1) 
• Human bocavirus (1) 
• Influenza A (1) 
• Parainfluenza 3 (1) 
• Respiratory scyntial  A  (4) 
 
  
• Adenovirus, (11) 
• Enterovirus (7) 
• Influenza B (1) 
• Human rhinovirus (18) 
• Human bocavirus  (2) 
• Parainfluenza 1(2)  
• P parainfluenza 3 (1) 




4.6.2 CMV comparison outcome between recurrent wheeze vs. infection.  
A total of58 patients were tested for CMV in this study. Of these, 26 were from the chronic 
wheezer category and 32 were from the recurrent infection category.   
7 Patients  in the recurrent wheezer category  tested negative and 19 tested positive. Out of 
the recurrent infection category, 10 tested negative and 22 tested positive.  
 








Chapter 5: Discussion.  
 
  
5.1. Discussion.  
In normal individuals 80-90% of cells recovered from BALF are macrophages, followed by 
5-15% lymphocytes and 3% neutrophils and 1% eosinophils respectively.  This BALF 
cellular profile is similar in paediatric patients. If a patient presents with no obvious 
diagnosis, formulating a final diagnosis on very non-specific symptoms is often results in a 
diagnosis of exclusion being made. Performing cytological analysis on paediatric BALF may 
be useful in the determination of the cellular constituents within the BALF thus ruling out 
certain pulmonary conditions.   
This study involved 90 paediatric patients with the clinical presentation of a recurrent wheeze 
with or without an accompanying recurrent infection.   
When comparing the mean ages, the broad categories of recurrent wheezer vs recurrent 
infection, their age mean differed by approximately 4 months, with the recurrent wheezers 
being younger in age. When looking at the mean ages of the sub-categories, it was seen that 
GORD patients were primarily younger (15.54 months) compared to the 
infection/inflammation category(24.95 months).   
The differential cell counts, where very similar across the categories and revealed no 
statistical significance between the broad category of recurrent wheezer vs. recurrent 
inflammation. The differential cell counts revealed that if compared to the “norm” of 80% 
macrophages, their counts were greatly decreased and their neutrophil count was almost 18 
times greater than what is considered to be normal.   
When comparing the carbon, lipid and haemosiderin-laden macrophages of the 2 broad 
categories, although not statistically significant, the analysis revealed that there was a greater 
percentage of carbon-laden macrophages in the recurrent wheezer (6.258%) compared to the 
recurrent infection category(4.718%), whereas the recurrent infection category had higher 
lipid-laden macrophage percentage (8.499%)and haemosiderin-laden macrophage percentage 
(8.900%) compared to percentages seen in the chronic wheezer category for lipid-laden 




A potential source of inaccuracy pertaining to cell quantitation may be due to inconsistency 
during interpretation of the measuring tools or variables which are subjective; these variables 
include cellular quantitation of leukocytes and alveolar macrophages, cellularity of the 
cytospin, quality of the stain the amount of phagocytosed material. Interobserver variability 
and the aforementioned parameters may result in quantitation and grading disparities.
55,57,58
 
Although not statistically significant, the statistical analysis revealed that the subcategory 
comparison revealed chronic wheezers have a higher mean carbon-laden macrophage 
percentage (2.27795%) compared to infection/inflammation (2.4845%); structural 
abnormality(0.3291%) and GORD(2.08%)  sub-categories. The comparison also revealed that 
GORD patients are both younger in their mean age and have the lowest mean haemosiderin 
and lipid-laden macrophage score indicating that not all GORD patients aspirate and thus 
BALF in paediatric GORD patients can assist in excluding the diagnosis of GORD 
pulmonary aspiration disease.  
All of the immunoglobulins were elevated in the recurrent infection category compared to 
recurrent wheezers. When the subcategories were compared, there was a fairly even 
distribution but IgA in the recurrent wheezer category was slightly decreased (7.69%) 
compared to the other sub-categories which revealed 13.04% in the infection/inflammation 
subcategory and 14.29% in the structural abnormality subcategory.. The CRP analysis in the 
sub-groups revealed GORD as having the highest elevated serum CRP parameter.    
Barring the minority of patients who had a positive outcome, the TB and cystic fibrosis 
investigations were negative in the patients involved in this study  
The microbiological investigations in the study were similar in the 2 broad category groups, 
however it revealed that a greater variety of cultured micro-organisms were found in the 
recurrent infection group. The opposite was found in the respiratory virus virology BALF 
investigations whereby a larger variety of viruses were isolated in the BALF of recurrent 
wheezers when compared to recurrent infection.  
   
In this study, the overall agreement was that none of the tests were of statistical significance 
used in the investigation of paediatric chronic wheezers were significant for the formulation  
of a specific diagnosis, or ability to place this group of children into a specific diagnostic 




study. There is adequate room to elaborate on this study by barring the exclusion criteria and 
performing statistical analysis on all paediatric BALF received at Tygerberg hospital by the 
paediatric pulmonology unit; collaborating with a private cytology laboratory that processes 
BALF to ascertain the difference between carbon-laden macrophages of children in a private 
vs government setting; explore automation as a potential method for cellular quantitation in 
our setting as well as including a test for pepsin on GORD patients.  In this way hopefully 
decrease the time spent on processing the samples and interobserver variability, truly 
differentiate between aspirated gastric content and aspirated lipid as culturally some mothers 
feed their babies oil in our setting.  Further studies into fine-tuning the applications of BALF 
can decrease the turn-around time for the test and improving the accuracy as well as provide 





Chapter 6: Conclusion.  
 
6.1 Conclusion  
  
The primary aim of paediatric BALF specimen collection and analysis from the pulmonology 
unit at Tygerberg hospital is to assist in the diagnosis of GORD aspiration pulmonary disease, 
an infective pathology, specific diagnosis’ such as alveolar proteinosis, atopy related 
hypersensitivity conditions or to assist in a diagnosis of exclusion.   
Although not necessarily a diagnostic test, the cytological analysis of paediatric BALF should 
not be disregarded. The time-consuming nature of the test may be improved if the option of 
electronic cell counts were to be performed. In addition, this test may be of more benefit to 
the clinician and subsequently the patient if more accurate investigations such as pepsin and 
α-lactalbumin immunocytochemical stains were to be utilized. This however is not current 
practice in our laboratory due to a lack of resources, Should future studies reveal that this aids 
the clinician in their final diagnosis then this will be added to our panel of tests performed on 
BALF. 
With the global increase in interest in environmental air pollution and emerging studies 
involving pulmonary disease development and exacerbation in relation to inhaled particulate 
matter; and its adverse effect on paediatric patients (in light of their behavioural and 
physiological factors), including a carbon-laden macrophage index and correlating it to a 
larger sample size not confined to a category of recurrent wheeze may provide much needed 
information that can only be obtained from a third world setting. Further investigations 
involving the size and composition of particulate matter and carbon loading of the alveolar 
macrophages in a paediatric group with a clinical correlation may also add to value to the 
current literature and bring global awareness to a seemingly innocuous ambient air 
constituents.   
This study has demonstrated that routine cytology processing of paediatric BALF that were 
obtained via a minimally invasive, BAL procedure performed by skilled pulmonologists 
could assist in the exclusion of various pulmonary diseases related to a chronic wheeze and 




The cytology differential cell count and grading of carbon, lipid and haemosiderin as well as 
clinical pathology and virology investigations did not reveal any significant results with 
regards to placing these children into a sub-classification or determining if the amount of 
phagocytosed carbon corresponds to an increased risk of developing chronic lung injury. 
Additional studies with a much larger sample size and correlation to a “normal” group are 
needed.  
  








   
  
  










Appendix 1(a): Dr Chase BALF processing and cell count method.  
This method was presented at the 37th Annual Conference of the Anatomical Society of 
Southern Africa, 2007.22-25 April.  
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Appendix 2: Papanicolaou staining technique.  
A 0.5% hydrochloric acid working solution is prepared by adding 5ml if 32% HCL to 995ml’s of 
distilled water. A working solution of 1% lithium carbonate is prepared by adding 10ml of LiCO3 






Appendix 3: Rapi-diff staining method   
  
  















Appendix 5: Perl’s Prussian blue staining technique.  
A working ferrocyanide solution is prepared by adding 20ml’s of 1% aqueous potassium 
ferrocyanide to 20ml’s of 2% aqueous hydrochloric acid  
 




























































Appendix 9: MGIT 960 package insert.  
  
Method: as per MIC1222 (Q-Pulse/docs/active/MIC12225v9)  
1. Sample reagent buffer supplied in the kit is transferred to the specimen in a 2:1 
volume ratio.  
2. The lid of the container is securely closed and the specimen is vortexed for 10 
seconds  
3. The specimen is incubated for 10 minutes at room temperature and then vortexed 
once again for another 10 seconds.  
4. The sample is incubated at room temperature for an additional 5 minutes  
5. A Xpert/MTB/RIF Ultra cartridge is labelled with the sample ID  
2ml of the processed sample transferred to the Xpert/MTB/RIF Ultra cartridge and loaded 
































































































Appendix 12: Gram stain technique and classification  
  
Method as per MIC1208(Q-Pulse/docs/active/MIC1208v5)  
1) A smear is made of the sediment of BALF following centrifugation.   
2) The smear is allowed to air dry and is fixed with a low heat.   
3) Methyl violet solution is applied for 30seconds.  
4) The slide is rinsed with water to remove excess methyl violet solution.  
5) Gram’s iodine solution is applied for 30-60seconds  
6) The slide is rinsed with water to remove excess gram’s iodine.  
7) The slide is flooded with acetone until no more colour appears to flow from the 
smear, 1-3seconds.  
8) The slide is rinsed with water to remove excess acetone.  
9) Gram’s dilute carbol fuchsin is applied for 30secconds.  
10) The slide is rinsed with water to remove excess carbol fuchsin.  
11) The slide is carefully blotted and dried with gentle heat.  
12) The smear is read microscopically using oil immersion and a 100x objective to 
determine the presence and type of organism.  





Appendix 13: BALF microbiology culture method.  
Method as per MIC1204(Q-Pulse/docs/active/MIC1204v6)  
1) A purulent portion of the specimen is selected using a loop or sterile swab.  
2) The various plates are inoculated with specimen are:   
• Blood agar for streptococcus pneumoniae   
• MacConkey agar for the isolation and differentiation of Gram-negative bacilli 
such as staphylococcus aureus and enterobacteria  
• Chocolate agar for the isolation of Haemophilus, Neisseria and Moraxella spp.  
• Columbia blood agar for the isolation of pneumococci.  
  
3) Plates are anaerobically incubated at 35̊C  
4) Morphological characteristics of cultured colonies are read to determine what  
causative agent in   
5) If morphological characteristics of the cultured colonies are indistinct, a second gram 












Appendix 14: Sweat test processing method  
Method as per CHE0705 (Q-Pulse/docs/active/CHE0705v5)  
1) Filter paper is placed in 4 labelled acuvettes with lids securely closed.  
2) Acuvettes are weighed and weight is recorded in grams.  
3) Gauze swabs soaked with pilocarpine nitrate are placed on the anode.  
4) Gauze swabs soaked in magnesium chloride are placed on the cathode.  
5) Proposed sites for  iontophoresis such as the inner arm are washed and dried.  
6) The anode is placed on the cleaned site and the cathode is placed on the opposite surface of 
the arm.  
7) The current is switched on and slowly increased to 4mA.  
8) Current is maintained for 5 minutes, current is then slowly reduced to zero. The current is 
switched off and electrodes are removed.  
9) After stimulation, the pilocarpine area is washed thoroughly with distilled water and dried.  
10) Filter paper from an acuvette is placed on the dried area using forceps and securely covered 
with a square of polythene.  
11) The patch is left for 30 minutes, removed with clean forceps and placed in the initial acuvette.  
12) If the filter paper seems dry and the sweat weighs less than 0.05g, the area can be re-
stimulated.  
13) The sweat is extracted from the filter paper by adding a calibration standard 2 solution as per 
manufacturer’s guidelines and pressed down firmly until filter paper is completely covered by 
the liquid.  
14) The container is allowed to stand at room temperature for 2 hours.  
15) The acuvettes are vortexed until the paper is thoroughly mashed.   
16) The contents of the acuvette is placed into an Eppendorf and microfuged for 4 minutes at 
13000rpm.  
17) The supernatant is placed in the Synchron CX3 sweat analyser for chloride and sodium 




















Appendix 16: Cobas c  Tina-quant IgA Gen.2 package insert.  
The reagents used as per manufacturer’s guidelines are the:  
R1) TRIS buffer 20mmol/L, pH 8.0; NaCl 200mmol/L; polyethylene glycol: 3.6%, 
preservative.  
R2) Anti-human IgA antibody (goat): dependent on titre; TRIS buffer: 20mmol/L, pH 8.0; 
NaCl: 150mmol/L; preservative.  









Appendix 17: Cobas c  Tina-quant IgG Gen.2 package insert.  
The reagents used as per manufacturer’s guidelines are the:  
R1) TRIS buffer 20mmol/L, pH 8.0; NaCl 200mmol/L; polyethylene glycol: 3.6%, 
preservative.  
R2) Anti-human IgG antibody (goat): dependent on titre; TRIS buffer: 20mmol/L, pH 8.0; 
NaCl: 150mmol/L; preservative.  




















Appendix 18: Cobas c  Tina-quant IgM Gen.2 package insert.  
The reagents used as per manufacturer’s guidelines are the:   
R1) TRIS buffer 20mmol/L, pH 8.0; NaCl 200mmol/L; polyethylene glycol: 3.6%, 
preservative.  
R2) Anti-human IgM antibody (goat): dependent on titre; TRIS buffer: 20mmol/L, pH 8.0; 
NaCl: 150mmol/L; preservative.  























Appendix 19: Cobas c  C-Reactive Protein Gen.3 package insert  
The reagents used as per manufacturer’s guidelines are the:  
R1): TRISa) buffer with bovine serum albumin; preservative.  
R2): Latex Particles coated with anti-CRP(mouse) in glycine buffer; 
immunoglobulins(mouse); preservative.  























Appendix 20(a): Anyplex® II RV16 PCR system package insert.  
Samples should be transported in viral transport medium, if not, viral transport medium is to 
be added to the sample. . Samples are processed at Tygerberg virology as per 




























Appendix 21(a): : REALSTAR CMV PCR KIT package insert  
Samples should be transported in viral transport medium, if not, viral transport medium is to 
be added to the sample. Samples are processed at Tygerberg virology as per VIR0624 (Q- 
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